Item 9A. Controls and Procedures
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures
that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act
is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls
are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the
chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
As required by Rules 13a-15
and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness
of the design and operation of our disclosure controls and procedures as of December 31, 2025. Based upon their evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and
15d-15(e) under the Exchange Act) were effective, Accordingly, management believes that the financial statements included in this
Annual Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Management’s Report on Internal Controls
Over Financial Reporting
This Annual Report on Form
10-K does not include a report of management’s assessment regarding internal control over financial reporting or an attestation
report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public
companies.
Changes in Internal Control over Financial
Reporting
None.
Item 9B. Other Information
None .
Item 9C. Disclosure Regarding Foreign Jurisdictions
that Prevent Inspections.
Not applicable.
67
PART III
Item 10. Directors, Executive Officers and Corporate
Governance.
Directors and Executive Officers
Our directors and executive officers are as follows:
Name
Age
Position(s)
Mohsin Y. Meghji
61
Chairman of the Board of Directors
Robert Rivas (“Reeve”) Collins
50
Chief Executive Officer
Matthew Perkal
41
Chief Operating Officer and Director
Eric Greenhaus
32
Chief Financial Officer
Chinh Chu
59
President
Chris Chaice
56
Executive Vice President
Charles Garner
63
Executive Vice President and Secretary
Benjamin Fader-Rattner
44
Director
Thomas Fairfield
67
Director
Edward Murphy
57
Director
Paul Kopsky
61
Director
Franklin Tsung
38
Director
Mohsin Y. Meghji serves
as Chairman of the Company’s board of directors (the “Board”). Mr. Meghji was the principal sponsor of M III
Acquisition Corp. from 2015 to 2019, M3-Brigade Acquisition II Corp. from 2020 to 2023, M3-Brigade Acquisition III
Corp. from 2021 to 2023 and M3-Brigade Acquisition IV Corp. from 2021 to 2022. Mr. Meghji currently serves as Chairman of M3-Brigade
Acquisition VI Corp.’s board of directors. Mr. Meghji has served as the Managing Partner of M3 Partners, LP since 2015 and
is a nationally recognized U.S. turnaround professional with a track record of building value across a wide range of sectors, including
power, energy and industrials. M3 Partners is a merchant banking, investment and restructuring advisory firm founded by Mr. Meghji
which provides operational, strategic and financial advisory solutions to support complex businesses at inflection points in their growth
trajectory. Mr. Meghji has more than 30 years of advisory and management experience in building value in companies that are
facing financial, operational or strategic inflection points and transitions. He has accomplished this through both operating management
and financial advisory roles, often in partnership with some of the world’s leading financial institutions, private equity firms
and hedge fund investors.
Mr. Meghji has led the
repositioning of, and driven value creation at, numerous businesses over the past two decades in an operating management or financial
advisory capacity. In his capacity as a restructuring and financial advisory professional, Mr. Meghji has served periodically as
Chief Restructuring Officer (or in an analogous position) of companies which elected to utilize bankruptcy proceedings as a part of their
financial restructuring process and, as such, he served as an executive officer of various companies which filed bankruptcy petitions
under federal law, including, without limitation, Mondee Holdings, Inc., True Value Company, L.L.C. and Zachry Holdings, Inc. in 2024,
Sorrento Therapeutics, Inc. and Whittaker Clark & Daniels, Inc. in 2023, 245 Park Avenue Property LLC and 181 West Madison Property
LLC in 2021, PWM Property Management LLC in 2021, Seadrill Partners LLC, Sable Permian Resources, LLC and Sanchez Energy Corporation in
2020, Barneys Inc. in 2019, and Sears Holdings Corporation in 2018. In that same capacity, Mr. Meghji also has periodically served
as an independent director of companies, some of which similarly elected to utilize bankruptcy proceedings, including Philadelphia Energy
Solutions Refining and Marketing LLC from August 2017 through March 2018, Toys ‘r Us from September 2017 through
September 2018, Full Beauty Brands from August 2018 through February 2019, Intelsat Envision Holdings from May 2020
through March 2022, Frontier Communications from 2019 through 2021 and SHOPKO from 2018 through 2019. Mr. Meghji’s most
recent corporate management role was at Springleaf, a subprime consumer finance company (now known as OneMain Holdings, Inc. (NYSE: OMF)),
where he served as Executive Vice President and Head of Strategy and as Chief Executive Officer of its captive insurance companies, Merit
Life Insurance Co. and Yosemite Insurance Company, from 2012 to 2014. These insurance companies provided life, property and casualty insurance
coverage to Springleaf’s customers. Springleaf was created in late-2010 when American International Group, Inc. sold 80% of
its subsidiary, American General Finance Inc., to affiliates of Fortress Investment Group LLC. At the time of the sale, American
General Finance Inc. provided consumer loans, retail financing and mortgages to more than one million families through more than 1,100
branches located across the United States, Puerto Rico, the Virgin Islands and the United Kingdom. After multiple years of operating
losses, Springleaf turned profitable in 2013 as a result of the strategic, management and operational improvements implemented by its
new ownership and management team, evidencing a significant turnaround in its performance. Springleaf went public in October 2013
at a $1.95 billion valuation. As part of its senior management team and Head of Strategy for the company, Mr. Meghji played
a key role in this successful transition.
68
Robert (“Reeve”)
Collins serves as our Chief Executive Officer and is an entrepreneur in the digital asset and financial technology sectors
with over a decade of experience building blockchain-based financial infrastructure. Mr. Collins co-founded Tether (USDT), the first
and most widely adopted stablecoin, and served as its founding Chief Executive Officer from September 2013 to September 2015.
Mr. Collins subsequently co-founded BLOCKv and later SmartMedia Technologies, a Web3 platform focused on programmable assets
and enterprise engagement solutions, where he was actively involved from 2017 until 2023. Mr. Collins has worked extensively in tokenized
financial systems, digital asset markets and blockchain-based payments infrastructure. Since 2024, Mr. Collins has co-founded and
served as Chairman of STBL, a stablecoin protocol, and WeFi, an on-chain financial platform, focused on blockchain-enabled banking
infrastructure. Through these roles, Mr. Collins has led the development of digital asset products and infrastructure intended to support
stablecoin adoption and blockchain-based financial services. Mr. Collins received a B.A. in Marketing and Finance from Washington
State University.
Matthew Perkal ,
serves as our Chief Operating Officer and a director on the Board. Mr. Perkal has also served as an Executive Vice President of M3-Brigade Acquisition II
Corp. and as Chief Executive Officer of M3-Brigade Acquisition III Corp. and M3-Brigade Acquisition IV Corp. Mr. Perkal
currently serves as Chief Executive Officer and as a director of M3-Brigade Acquisition VI Corp. Since 2010, Mr. Perkal has led Brigade
Capital Management, LP’s industry coverage for various sectors including retail, consumer, gaming and lodging, and has structured
and led many of the firm’s successful deals in the private credit space including Barney’s and Sears. Mr. Perkal currently
serves on the board of directors for Guitar Center Inc. He also served as a Director of Greenfire Resources Ltd. (NYSE: GFR) from
the time of its merger with M3-Brigade Acquisition II Corp. in September 2023 through December 2024. In his capacity
as a restructuring and financial advisory professional, Mr. Perkal served as an independent director of companies, some of which
elected to utilize bankruptcy proceedings, including Guitar Center from December 2020 through present and Gymboree from September 2017
through June 2020. Prior to joining Brigade, Mr. Perkal worked at Deutsche Bank as an Analyst in the Leveraged Finance Group
from 2008-2010. In that capacity, Mr. Perkal also spent time on the Leveraged Debt Capital Markets Desk, selling both bank and
bond deals. Mr. Perkal received a BS in Economics with a concentration in Finance and Accounting from the University of Pennsylvania’s
Wharton School of Business.
Eric Greenhaus serves
as our Chief Financial Officer. Mr. Greenhaus has been employed by M3 Partners, LP since March 2020, where he currently is a
Director. During his tenure at M3 Partners, Mr. Greenhaus has provided restructuring advisory and performance improvement services,
as well as assisting with SEC reporting and transaction modeling for M3-Brigade Acquisition II Corp. and M3-Brigade Acquisition III
Corp. Mr. Greenhaus currently serves as Chief Financial Officer of M3-Brigade Acquisition VI Corp. Prior to joining M3 Partners, Mr. Greenhaus
worked at KPMG in their Deal Advisory & Strategy department from March 2018 through February 2020. Mr. Greenhaus
also worked at Deloitte as an audit associate from September 2016 to February 2018, during which he maintained a Certified Public
Accounting license. Mr. Greenhaus has extensive experience auditing and analyzing financial statements, conducting financial due
diligence, managing liquidity, creating financial and forecasting models, business planning, and advising senior executives on strategic
initiatives. Mr. Greenhaus received a Master of Accounting from the University of Michigan in 2016 and a B.A. in Business Administration
from the University of Michigan in 2015. He currently sits on the board of directors of Triton Financial Limited.
69
Chinh Chu serves
as our President. Mr. Chu is the Senior Managing Partner of CC Capital, a private investment firm which he founded in 2016. Mr. Chu
has over 30 years of investment and acquisition experience. Before founding CC Capital, Mr. Chu worked at Blackstone from 1990 to
2015. Mr. Chu was a Senior Managing Director at Blackstone beginning in 2000 and previously served as Co-Chair of Blackstone’s
Private Equity Executive Committee and as a member of Blackstone’s Executive Committee. Mr. Chu also served as the Chief Executive
Officer and Director of CC Neuberger Principal Holdings II, a special purpose acquisition company he co-founded, from May 2020 until the
consummation of the business combination with Getty Images, Inc. to form Getty Images Holdings, Inc. in July 2022. Mr. Chu served
as Chief Executive Officer and director of CC Neuberger Principal Holdings I from January 2020 until the consummation of the business
combination with E2open Holdings, LLC in February 2021. Mr. Chu has served on the board of directors of Getty Images Holdings, Inc.
since July 2022. He previously served as a director of E2open Holdings, LLC, Dun & Bradstreet Holdings, Inc., Kronos Incorporated,
SunGard Data Systems, Inc., Stiefel Laboratories, Freescale Semiconductor, Ltd. Biomet, Inc., Alliant, Celanese Corporation, Nalco Company,
DJO Global, Inc., HealthMarkets, Inc., Nycomed, Alliant Insurance Services, Inc., the London International Financial Futures and Options
Exchange, Graham Packaging and AlliedBarton Security Services.
Chris Chaice serves
as our Executive Vice President. Since November 2012, Mr. Chaice has advised the M3-Brigade investment team with respect
to structuring investments, restructurings, bond and bank debt covenants, and litigations. Mr. Chaice served as a Senior Credit Attorney
at Brigade Capital Management, LP from November 2012 until January 2021 and as Senior Attorney, Private Credit and Restructuring,
from January 2021 until March 2022. Mr. Chaice currently serves as Executive Vice President of M3-Brigade Acquisition VI Corp.
In his capacity as a restructuring and financial advisory professional, Mr. Chaice served as an independent director of companies,
some of which elected to utilize bankruptcy proceedings, including Sanchez Energy Corporation from October 2023 through present.
Since April 2022, Mr. Chaice has served as a Partner & Head of Distressed Research at Brigade. Prior to joining Brigade
Capital Management, LP, from July 2008 to October 2012, Mr. Chaice worked at Covenant Review, a fixed-income research
firm, where he analyzed debt covenants, complex capital structures, and bankruptcy issues. Additionally, from August 2006 to May 2008,
Mr. Chaice worked as an Analyst at Southpaw Asset Management, where he analyzed event-driven investment opportunities relating
to bankruptcies, restructurings, liquidations and litigation. Prior to Southpaw, Mr. Chaice practiced law at Cahill Gordon &
Reindel from September 1999 to September 2005, and at Willkie Farr & Gallagher from September 2005 to August 2006,
where he specialized in capital markets transactions, primarily representing underwriters of high yield bonds and leveraged loans. Mr. Chaice
received a BA in Political Science from Syracuse University and a law degree, cum laude, from New York University School of Law.
Charles Garner serves
as a director on our Board and is an accomplished business and legal professional, with over 35 years of experience in M&A, corporate
finance and business management. He was actively involved in all aspects of the business plan of the M III Acquisition Corp., M3-Brigade Acquisition II
Corp., M3-Brigade Acquisition III Corp., M3-Brigade Acquisition IV Corp. and BM3EAC Corp., including formation, management
and business combination activities. Mr. Garner currently serves as Executive Vice President of M3-Brigade Acquisition VI Corp. Mr. Garner
joined M3 Partners, LP in 2015 and currently serves as Senior Managing Director and General Counsel of M3 Partners. Mr. Garner began
his career in 1987 as an attorney at Simpson Thacher & Bartlett, a leading international law firm, where he rose to become a
partner in the corporate/banking group. Mr. Garner has served as Executive Managing Director and Chief Operating Officer of Island
Capital Group LLC, a real estate-focused merchant banking firm, where he played key roles in the formation of Emirates National Securitisation
Corporation (a joint venture with various entities of the Government of Dubai to create a mortgage securitization market in Dubai) and
Island Global Yachting (a leading owner and operator of luxury and megayacht marinas). Among other positions, Mr. Garner also has
served as Interim CEO of a European industrial software company focused on the utilities industry. Mr. Garner served as a director
of IEA (with a short period of interruption) from March 2018 through its merger with MasTec, Inc. in October 2022 and served
as the Chair of various Special Committees of independent directors of IEA in the review of financing and related transactions that led
to the material increase in the equity and enterprise values of IEA during that period.
70
Benjamin Fader-Rattner serves
as a director on our Board and has been a Managing Director at Nexus Capital Management LP since December 2023 where he focuses
on credit opportunities. Prior to joining Nexus, Mr. Fader-Rattner led Space Summit Capital LLC, a special situations investment
fund which he founded in January 2021. Mr. Fader-Rattner currently serves as a director of M3-Brigade Acquisition VI Corp. Previously,
Mr. Fader-Rattner served as a director of the Third SPAC from October 2021 — September 2023 and he
also served as President and a director of Osiris Acquisition Corp., a publicly listed special purpose acquisition company, from May 2021
— May 2024. Prior to founding Space Summit Capital LLC, Mr. Fader-Rattner was a Managing Director at Canyon Partners,
where he led investments across the capital structure in several industries including retail and consumer, from 2008 to July 2020.
Prior to Canyon, Mr. Fader-Rattner was an analyst at Glenview Capital in 2007, where he invested primarily in debt opportunities,
an associate at The Carlyle Group from 2005 to 2007, where he focused on leveraged buyout transactions, and an analyst at Bear, Stearns &
Co. Inc. from 2003 to 2005. Mr. Fader-Rattner received a B.S. in Economics, summa cum laude, from The Wharton School at the
University of Pennsylvania.
Thomas Fairfield serves
as a director on our Board with over 40 years of experience in M&A, corporate finance and business management. Mr. Fairfield
serves as the Chief Financial Officer, Chief Operating Officer and Secretary of byNordic Acquisition Corporation (OTC: BYNO). Mr. Fairfield
provides strategic business consulting services through Cambio Group LLC (“Cambio”) that he founded and has owned since July 2018.
In connection with recent Cambio engagements, Mr. Fairfield served as Chief Restructuring Officer of Rhino Resource Partners LP (“Rhino”),
an energy company, from May 2020 through the effective date of the plan of liquidation in Rhino’s Chapter 11 bankruptcy
in February 2021, as President and Chief Executive Officer and a member of the board of managers of Journey Group Acquisition Co.,
LLC, a death care services company, from October 2018 to December 2023, and as President and Chief Restructuring Officer of
V3 Commodities Group Holdings, LLC, a specialty finance company serving the retail energy services sector, from April 2024 through
December 2024. From November 2021 through the fourth quarter of 2023 Mr. Fairfield has served as independent investor representative
for investment funds managed by White Oak Partners and Periscope Capital Inc. Mr. Fairfield also served as a member of the board
of managers of Casablanca Holdings GP LLC, a holding company for Apple Leisure Group, a hospitality and travel services company, from
May 2020 to December 2020 and has been a member of the board of managers of Family Services Holdings, LLC, a death care services
company, since June 2021. Mr. Fairfield has a Juris Doctorate degree from Georgetown University Law Center and a B.S.F.S. from
Georgetown University. He is admitted to the bar of the states of Connecticut, Pennsylvania, New York, and the District of Columbia,
and is a member of the American Bar Association.
Edward Murphy serves
as a director of our Board and is a seasoned financial services professional with over 35 years of expertise, having held roles
in sales, trading, portfolio management, capital raising, financial analysis, structuring, and has managed investment vehicles with over
$11 billion dollars in assets. Mr. Murphy has held multiple positions across various financial institutions, such as Goldman
Sachs & Co., Guggenheim Partners, and Cantor Fitzgerald & Co. Mr. Murphy founded and contributed to the development
of a secondary trading platform for Institutional Credit Partners and has provided capital raising, financial analysis and sales services
to Propellr, a creation, management, and servicing platform for digitally held assets. In 2015, Mr. Murphy founded Reade Street Ventures,
L.L.C., a financial advisory firm engaged in capital market activities spanning the real estate, FinTech, art finance and blockchain sectors.
Throughout his career, Mr. Murphy has pioneered disruptive financial strategies, leveraging smaller platforms to democratize investment
products traditionally exclusive to large firms. Mr. Murphy received a Bachelor of Arts in Philosophy and Economics from Columbia
University.
Paul Kopsky serves
as a director of our Board and has over 30 years of experience in accounting and financial matters. Since 2020, Mr. Kopsky has
served as the owner and principal of Hawk Advisory, LLC (“HAWK Advisory”), a consulting company providing executive leadership
and consulting services in connection with various M&A activities, debt financings, restructuring, financial, accounting, and operational
matters. Mr. Kopsky also currently serves as the principal of Cambio Group LLC (“Cambio”), a consulting firm providing
strategic business consulting services to private equity firms across the real estate, financial services and healthcare industries. Mr.
Kopsky currently serves as Chief Executive Officer and member of the board of managers of Family Services Holdings LLC, a death care services
company. Mr. Kopsky has held several key leadership positions in privately owned companies in connection with his engagements through
Cambio and HAWK Advisory. Previously, Mr. Kopsky served as interim Chief Operating Officer of Vantem Global, Inc., a modular systems
construction company and from October 2024 to July 2025, Mr. Kopsky served as the Vice President of V3 Commodities Group
Holdings, LLC, a specialty finance company engaged in the retail energy services sector. Mr. Kopsky also served as the Chief Operating
Officer of MCRM Fertility, from May 2021 to October 2024. From October 2018 to December 2023, Mr. Kopsky served
as the Chief Operating Officer and member of the board of managers of Journey Group Acquisition Co., LLC, a death care services company.
Mr. Kopsky served on the board of Paramount Financial Group and Paramount Bank from January 2018 until March 2024.
71
Prior to providing strategic
business consulting through HAWK Advisory and Cambio, Mr. Kopsky served in various executive finance and accounting leadership roles,
including, Chief Financial Officer of RAIT Financial Trust (NASDAQ-RAIT) from February 2017 to August 2017, and Executive Vice
President and Chief Operating Officer for Hunt Companies, Inc., a diversified financial services holding company, from September 2013
to November 2016. From March 2011 to September 2013, Mr. Kopsky was Managing Director in the Investment Banking and
Project Finance department of Jefferies & Company, Inc., a global investment banking company and broker-dealer. Additionally,
Mr. Kopsky has held executive financial leadership roles at Capmark Financial Group, Inc., a publicly listed commercial mortgage
company, Reinsurance Group of America, Incorporated (NYSE-RGA), a publicly traded life reinsurance company, Nationwide Insurance Group,
a diversified insurance and financial services company, Lincoln Financial Group (NYSE-LNC), a publicly-traded life insurance company,
and Conning Corporation (NASDAQ-CNNG), an asset manager, and its majority owners — MetLife, an insurance company, and
Swiss Re, a reinsurance company. Mr. Kopsky earned his BSBA in accounting and finance from Creighton University and an MBA from the
University of Chicago.
Franklin Tsung serves
as a director of our Board and is a veteran financial services executive with nearly 15 years of leadership experience operating
at the intersection of private equity and enterprise software. Since 2006, Mr. Tsung has served as Chief Executive Officer of Blackcrown
Inc., an independent principal firm and registered investment advisor focusing on private equity advisory with an emphasis on investment
origination advisory services and portfolio company advisory services. Since 2015, Blackcrown has been principal buy-side advisor,
working in coordination with institutional financial sponsors on over $7 billion in private equity processes. Additionally, Mr. Tsung
actively serves as the Chief Growth Officer for AppCrown LLC, a privately held financial technology company specializing in enterprise
data integration for independent registered investment advisors, broker-dealers, and insurance carriers in order to enhance advisor productivity,
scalability and regulatory compliance. Mr. Tsung started his career at Merrill Lynch and is a Certified Senior Advisor with the Society
of Certified Senior Advisors. Mr. Tsung matriculated from the Fu Foundation School of Engineering at Columbia University.
Number and Terms of Office of Officers and Directors
Our Board consists of seven
members and is divided into three classes with only one class of directors being appointed in each year, and with each class (except for
those directors appointed prior to our first annual general meeting) serving a three-year term. In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual general meeting until one year after the first fiscal year end following our listing
on Nasdaq. The term of office of the first class of directors, consisting of Mr. Fader-Rattner and Mr. Murphy, will expire
at our first annual general meeting. The term of office of the second class of directors, consisting of Mr. Fairfield and Mr. Tsung,
will expire at the second annual general meeting. The term of office of the third class of directors, consisting of Mr. Meghji, Mr. Perkal
and Mr. Kopsky, will expire at the third annual general meeting. Our officers are appointed by the Board and serve at the Board’s
discretion, rather than for specific terms of office. The Board is authorized to appoint officers as it deems appropriate pursuant to
our amended and restated memorandum and articles of association.
Director Independence
Nasdaq rules require that
a majority of the Board be independent within one year of our IPO. An “independent director” is defined generally as a person
who, in the opinion of the company’s board of directors, has no material relationship with the listed company (either directly or
as a partner, shareholder or officer of an organization that has a relationship with the company). We have five “independent directors”
as defined in Nasdaq rules and applicable SEC rules. The Board has determined that Mr. Fader-Rattner, Mr. Fairfield, Mr. Murphy, Mr. Kopsky
and Mr. Tsung are “independent directors” as defined in Nasdaq’s listing standards and applicable SEC rules. The independent
directors have regularly scheduled meetings at which only independent directors are present. Pursuant to Nasdaq’s phase-in rules
for newly listed companies, we had one year from the date on which we were first listed on Nasdaq to have an independent board of directors,
which we satisfied within the applicable time period.
Committees of the Board of Directors
Our board of directors has
three standing committees: an audit committee, compensation committee, and corporate governance and nominating committee. Subject to phase-in
rules, the rules of Nasdaq and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely
of independent directors. Each committee operates under a charter that was approved by our board and has the composition and responsibilities
described below.
72
Audit Committee
Our board of directors has
established an audit committee of the board of directors. Mr. Fader-Rattner, Mr. Fairfield, Mr. Murphy and Mr. Kopsky
serve as the members of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have three
members of the audit committee, all of whom must be independent. Mr. Fairfield, Mr. Fader-Rattner, Mr. Murphy and Mr. Kopsky
are each independent.
Mr. Kopsky serves as
the chairman of the audit committee. Each member of the audit committee is financially literate and the Board has determined that
Mr. Kopsky qualifies as an “audit committee financial expert” as defined in applicable SEC rules.
We have adopted an audit committee
charter, which details the principal functions of the audit committee, including:
● assisting
board oversight of (1) the integrity of our financial statements, (2) our compliance with
legal and regulatory requirements, (3) our independent registered public accounting firm’s
qualifications and independence, and (4) the performance of our internal audit function and
independent registered public accounting firm; the appointment, compensation, retention,
replacement, and oversight of the work of the independent auditors and any other independent
registered public accounting firm engaged by us;
● pre-approving
all audit and non-audit services to be provided by the independent registered public accounting
firm or any other registered public accounting firm engaged by us, and establishing pre-approval
policies and procedures; reviewing and discussing with the independent registered public
accounting firm all relationships the independent registered public accounting firm have
with us in order to evaluate their continued independence;
● setting
clear policies for audit partner rotation in compliance with applicable laws and regulations;
obtaining and reviewing a report, at least annually, from the independent registered public
accounting firm describing (1) the independent registered public accounting firm’s
internal quality-control procedures and (2) any material issues raised by the most recent
internal quality-control review, or peer review, of the independent registered public accounting
firm, or by any inquiry or investigation by governmental or professional authorities, within
the preceding five years respecting one or more independent audits carried out by the firm
and any steps taken to deal with such issues;
● meeting
to review and discuss our annual audited financial statements and quarterly financial statements
with management and the independent registered public accounting firm, including reviewing
our specific disclosures under “Management’s Discussion and Analysis of Financial
Condition and Results of Operations”; reviewing and approving any related party transaction
required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior
to us entering into such transaction; and
● reviewing
with management, the independent registered public accounting firm, and our legal advisors,
as appropriate, any legal, regulatory or compliance matters, including any correspondence
with regulators or government agencies and any employee complaints or published reports that
raise material issues regarding our financial statements or accounting policies and any significant
changes in accounting standards or rules promulgated by the Financial Accounting Standards
Board, the SEC or other regulatory authorities.
73
Compensation Committee
Our board of directors has
established a compensation committee. The members of our compensation committee are Mr. Fader-Rattner, Mr. Murphy and Mr. Fairfield. Mr.
Fairfield serves as chair of the compensation committee. Under the Nasdaq listing standards and applicable SEC rules, we are required
to have a compensation committee of at least two members, all of whom must be independent. Mr. Fader-Rattner, Mr. Murphy and Mr. Fairfield
are each independent. We have adopted a compensation committee charter, which details the principal functions of the compensation committee,
including:
● reviewing
and approving on an annual basis the corporate goals and objectives relevant to our chief
executive officer’s compensation, evaluating our chief executive officer’s performance
in light of such goals and objectives and determining and approving the remuneration (if
any) of our chief executive officer’s based on such evaluation;
● reviewing
and making recommendations to our board of directors with respect to the compensation, and
any incentive compensation and equity based plans that are subject to board approval of all
of our other officers;
● reviewing
our executive compensation policies and plans;
● implementing
and administering our incentive compensation equity-based remuneration plans;
● assisting
management in complying with our proxy statement and annual report disclosure requirements;
● approving
all special perquisites, special cash payments and other special compensation and benefit
arrangements for our executive officers and employees;
● producing
a report on executive compensation to be included in our annual proxy statement; and
● reviewing,
evaluating and recommending changes, if appropriate, to the remuneration for directors.
The amended and restated memorandum
and articles of association also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of
a compensation consultant, legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight
of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or
any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq
and the SEC.
Corporate Governance and Nominating Committee
We have established a corporate
governance and nominating committee of our board of directors. The members of the corporate governance and nominating committee are Mr. Fairfield,
Mr. Murphy and Mr. Fader-Rattner, and Mr. Fairfield serves as chair of the corporate governance and nominating committee.
Our board of directors has
adopted a corporate governance and nominating committee charter, which details the principal functions of the corporate governance and
nominating committee, including:
● identifying
and screening individuals for election to the Board, consistent with criteria approved by
the Board;
● recommending
to the Board the director nominees for election at each meeting of shareholders at which
directors will be elected (including incumbent directors seeking reelection that are subject
to the committee’s nomination process);
● overseeing
the Board’s annual self-evaluation process; and
● reviewing
and assessing the adequacy of the charter on an annual basis and recommend any proposed changes
to the Board for approval.
Our amended and restated memorandum
and articles of association also provides that the corporate governance and nominating committee may, in its sole discretion, retain or
obtain the advice of, and terminate, any search firm to be used to identify director candidates, and will be directly responsible for
approving the search firm’s fees and other retention terms.
74
We have not formally established
any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying
and evaluating nominees for director, our board of directors considers educational background, diversity of professional experience, knowledge
of its business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of its shareholders.
Prior to the initial business combination, our shareholders will not have the right to recommend director candidates for nomination to
our board of directors.
Compensation Committee Interlocks and Insider
Participation
None of our executive officers
currently serves, or in the past year has served, as a member of the compensation committee of any entity that has one or more executive
officers serving on our board of directors.
Code of Ethics
We have adopted
a Code of Ethics applicable to our directors, officers and employees (the “Code of Ethics”). The Code of Ethics codifies the
business and ethical principles that govern all aspects of our business. A copy of the Code of Ethics is attached as an exhibit to this
Annual Report. If we make any amendments to our Code of Ethics other than technical, administrative or other non-substantive amendments,
or grant any waiver, including any implicit waiver, from a provision of the Code of Ethics applicable to our principal executive officer,
principal financial officer, principal accounting officer or controller or persons performing similar functions requiring disclosure under
applicable SEC or Nasdaq rules, we will disclose the nature of such amendment or waiver on our website.
Insider Trading Policy
We have adopted an insider trading policy which governs the purchase, sale, and/or other dispositions of our securities by directors, officers and employees and other covered persons and is designed to promote compliance with insider trading laws, rules and regulations, and listing standards applicable to the Company. A copy of our Securities Trading Policy is attached as Exhibit 19.1 to this Annual Report.
Section 16 (a) Beneficial Ownership Reporting
Compliance
Section 16(a) of the Securities
Exchange Act of 1934, as amended, requires our executive officers, directors and persons who beneficially own more than ten percent of
our Class A Common Stock to file reports of ownership and changes in ownership with the SEC. These reporting persons are also required
to furnish us with copies of all Section 16(a) forms they file. Based solely upon a review of such Forms, we believe that there were no
delinquent filers during the year ended December 31, 2025.
75
Conflicts of Interest
Under Cayman Islands law,
directors and officers owe the following fiduciary duties:
(i) duty to act in good faith in what the director or officer
believes to be in the best interests of the Company as a whole;
(ii) duty to exercise powers for the purposes for which those powers
were conferred and not for a collateral purpose;
(iii) directors should not improperly fetter the exercise of future
discretion;
(iv) duty to exercise powers fairly as between different sections
of shareholders;
(v) duty not to put themselves in a position in which there is
a conflict between their duty to the Company and their personal interests; and
(vi) duty to exercise independent judgment.
In addition to the above,
directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably
diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same
functions as are carried out by that director in relation to the Company and the general knowledge skill and experience of that director.
As set out above, directors
have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit
as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized
in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted
in the memorandum and articles of association or alternatively by shareholder approval at general meetings.
Each of our officers and directors
presently has, and any of them in the future may have additional, fiduciary or contractual obligations to at least one other entity pursuant
to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if
any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she
has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present
such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. Our amended and restated
memorandum and articles of association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a
director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly
or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in,
or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any
director or officer, on the one hand, and us, on the other. We do not believe, however, that the fiduciary duties or contractual obligations
of our officers or directors will materially affect our ability to complete our initial business combination.
76
Below is a table summarizing
the entities to which our officers and directors currently have fiduciary duties or contractual obligations:
Individual
Entity
Entity’s
Business
Affiliation
Mohsin Y. Meghji
M-III Partners, LP
Financial Advisory Services
Managing Partner
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Executive Chairman
Chinh Chu
CC Capital
Financial Advisory Services
Founder and Senior Managing Partner
The Westaim Corporation
Financial Advisory Services
Executive Chairman
Arena Investors
Financial Advisory Services
Board Member
Ceres Life Insurance Company
Life Insurance
Board Member
Wilshire Advisors, LLC
Financial Advisory Services
Board Member
Getty Images Holdings, Inc.
Visual Media
Board Member
Robert Rivas (“Reeve”) Collins
Pi Technologies LTD
Quantum Capital
Stablecoin Platform
Financial Services
Co-Founder and Chairman
Co-Founder and Chairman
Holdings Ltd.
Matthew Perkal
Brigade Capital Management, LP
Investments
Partner - Head of SPACs and
Special Situations
Guitar Center Inc.
Retailer
Board Member
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Chief Executive Officer and Board Member
Eric Greenhaus
M-III Partners, LP
Financial Advisory Services
Director
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Chief Financial Officer
Chris Chaice
Brigade Capital Management, LP
Investments
Partner - Head of Distressed Research
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Executive Vice President
Charles Garner
M-III Partners, LP
Financial Advisory Services
Senior Managing Director & General Counsel
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Executive Vice President
Thomas Fairfield
By Nordic Acquisition Corporation
Special Purpose Acquisition Company
Chief Operating Officer and
Chief Financial Officer
by Nordic Manager LLC
Holding Company
President
Family Services Holdings, LLC
Holding Company
Board Member
Edward Murphy
Reade Street Ventures, L.L.C.
Financial Services
Manager
Paul Kopsky
Family Services Holdings, LLC
Holding Company
Board Member and
Chief Executive Officer
HAWK Partners, LLC
Holding Company
Managing Member
HAWWK Partners, LLC
Holding Company
Managing Member
Benjamin Fader-Rattner
Space Summit Capital LLC
Financial Services
Managing Member
Nexus Capital Management LP
Financial Services
Managing Member
M3-Brigade Acquisition VI Corp.
Special Purpose Acquisition Company
Board Member
Franklin Tsung
BlackCrown Inc.
Financial Services
Manager
77
In addition, our Sponsor and
our officers and directors may sponsor or form other SPACs similar to ours or may pursue other business or investment ventures during
the period in which we are seeking an initial business combination. As a result, our Sponsor, officers and directors could have conflicts
of interest in determining whether to present business combination opportunities to us or to any other SPAC with which they may become
involved. Any such companies, businesses or investments may present additional conflicts of interest in pursuing an initial business combination
target. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business
combination.
Potential investors should also be aware of the
following other potential conflicts of interest:
● Our
officers and directors are not required to, and will not, commit their full time to our affairs,
which may result in a conflict of interest in allocating their time between our operations
and our search for a business combination and their other businesses. We do not intend to
have any full-time employees prior to the completion of our initial business combination.
Each of our officers is engaged in several other business endeavors for which he may be entitled
to substantial compensation, and our officers are not obligated to contribute any specific
number of hours per week to our affairs.
● Our
initial shareholders currently hold founder shares and Private Placement Warrants. Our Original
Sponsor, Sponsor, officers and directors have entered into the Letter Agreement, pursuant
to which they have agreed to waive their redemption rights with respect to their founder
shares and Public Shares in connection with the completion of our initial business combination
or an earlier redemption in connection with the commencement of the procedures to consummate
the initial business combination if we determine it is desirable to facilitate the completion
of the initial business combination. Additionally, our Sponsor, officers and directors have
agreed to waive their rights to liquidating distributions from the Trust Account with respect
to their founder shares if we fail to complete our initial business combination within the
prescribed time frame, although they will be entitled to liquidating distributions from assets
outside the Trust Account. If we do not complete our initial business combination within
the prescribed time frame, the Private Placement Warrants will expire worthless. Furthermore,
our Sponsor, officers and directors have agreed not to transfer, assign or sell any of their
founder shares and any Class A ordinary shares issuable upon conversion thereof until the
earlier to occur of: (i) one year after the completion of our initial business combination
or (ii) the date following the completion of our initial business combination on which we
complete a liquidation, merger, share exchange or other similar transaction that results
in all of our shareholders having the right to exchange their ordinary shares for cash, securities
or other property. Notwithstanding the foregoing, if the closing price of our Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,
share consolidations, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after our initial business
combination, the founder shares will be released from the lockup. The Private Placement Warrants
(including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants)
will not be transferable until 30 days following the completion of our initial business combination.
Because certain of our officers and directors will own ordinary shares or warrants directly
or indirectly, they may have a conflict of interest in determining whether a particular target
business is an appropriate business with which to effectuate our initial business combination.
● Our
officers and directors may have a conflict of interest with respect to evaluating a particular
business combination if the retention or resignation of any such officers and directors was
included by a target business as a condition to any agreement with respect to our initial
business combination.
We are not prohibited from
pursuing an initial business combination with a business combination target that is affiliated with our Sponsor, officers or directors,
or completing the business combination through a joint venture or other form of shared ownership with our Sponsor, officers or directors.
In the event we seek to complete an initial business combination with a target that is affiliated (as defined in our amended and restated
memorandum and articles of association) with our Sponsor, officers or directors, we, or a committee of independent directors, would obtain
an opinion from an independent investment banking firm which is a member of FINRA or a valuation or appraisal firm stating that the consideration
to be paid by us in such an initial business combination is fair to our Company from a financial point of view. We are not required to
obtain such an opinion in any other context. Except as described herein, none of our Sponsor or any of our existing officers or directors,
or any entity with which they are affiliated, will be paid any finder’s fee, consulting fee or other compensation by the Company
prior to, or for any services they render in order to effectuate, the completion of our initial business combination (regardless of the
type of transaction that it is). However, we may pay consulting, success or finder fees to our independent directors, our advisors, or
their respective affiliates in connection with the consummation of our initial business combination.
78
We cannot assure you that
any of the above-mentioned conflicts will be resolved in our favor.
In the event that we submit
our initial business combination to our public shareholders for a vote, our Sponsor, officers and directors have agreed to vote their
founder shares, and they and the other members of our management team have agreed to vote their founder shares and any shares purchased
during or after the offering in favor of our initial business combination. The non-managing sponsor investors are not required to (i)
hold any units, Class A ordinary shares or public warrants they may have purchased in the IPO or thereafter for any amount of time, (ii)
vote any Class A ordinary shares they may own at the applicable time in favor of our initial business combination or (iii) refrain from
exercising their right to redeem their public shares at the time of our initial business combination. The non-managing sponsor investors
will have the same rights to the funds held in the Trust Account with respect to the Class A ordinary shares underlying the units they
may have purchased in the IPO or thereafter as the rights afforded to our other public shareholders.
Item 11. Executive Compensation.
Compensation Discussion and Analysis
None of our executive officers,
in such capacity, have received any cash compensation for services rendered to us. Our Sponsor, executive officers and directors, or any
of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf
such as identifying potential target businesses and performing due diligence on suitable business combinations. Further, we may pay consulting,
success or finder fees to our independent directors, our advisors, or their respective affiliates in connection with the consummation
of our initial business combination. We may also engage our Sponsor or an affiliate of our Sponsor as an advisor or otherwise in connection
with our initial business combination and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes
a market standard for comparable transactions. Our audit committee reviews on a quarterly basis all payments that were made to our Sponsor,
executive officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made from
funds held outside the Trust Account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any
additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses
incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination.
Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid
by the Company to our Sponsor, executive officers, or any of their respective affiliates, prior to completion of our initial
business combination.
After the completion of our
initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees
from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation
materials or tender offer materials furnished to our shareholders in connection with a proposed initial business combination. We have
not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management.
It is unlikely the amount of such compensation will be known at the time of the proposed initial business combination, because the directors
of the post-combination business will be responsible for determining executive officer and director compensation.
Any compensation to be paid
to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee
constituted solely by independent directors or by a majority of the independent directors on our board of directors.
79
We do not intend to take any
action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination,
although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with
us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions
with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability
of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision
to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for
benefits upon termination of employment.
Non-Employee Director Compensation
In June 2025, upon the
recommendation of our compensation committee, our board of directors approved certain compensation to be provided to the
Company’s non-employee directors for service on our board of directors and its committees, pursuant to a Non-Employee Director Compensation Plan adopted by our board of directors. The following table shows the
compensation that non-employee directors received for Board and Committee service, as applicable, in 2025.
The foregoing description
of the Non-Employee Director Compensation Plan does not purport to be complete and is qualified in its entirety by the terms and conditions
of the Securities Purchase Agreement, a copy of which is filed hereto as Exhibit 10.20 and incorporated by reference herein.
Description
Amount
($)
Annual Board Membership Fee
150,000
Annual Board Membership Equity Compensation
—
Annual Committee Membership Fee (per committee)
25,000
Annual Committee Chair Fee (per committee)
10,000
Per Meeting Fee
3,000
The following table provides
information regarding the compensation earned or paid in cash by our non-employee directors for the year ended December 31, 2025.
Name
Fees
earned or
paid in
cash
($)
Stock
awards
($)
Option
awards
($)
Non-equity
incentive
plan
compensation
($)
Nonqualified
deferred
compensation
earnings
($)
All other
compensation
($)
Total
($)
Mohsin Meghji
169,000
—
—
—
—
—
169,000
Thomas Fairfield
322,000
—
—
—
—
—
322,000
Matthew Perkal
165,000
—
—
—
—
—
165,000
Edward Murphy
292,000
—
—
—
—
—
292,000
Paul Kopsky
206,000
—
—
—
—
—
206,000
Benjamin Fader-Rattner
292,000
—
—
—
—
—
292,000
Franklin Tsung
165,000
—
—
—
—
—
165,000
Item 12. Security Ownership of Certain Beneficial
Owners and Management and Related Shareholder Matters.
The following table sets forth
information regarding the beneficial ownership of our ordinary shares as of the date of this Annual Report on Form 10-K. Unless otherwise
indicated, we believe that all persons named in the table have sole voting and investment power with respect to all of our ordinary shares
beneficially owned by them. The following table does not reflect record or beneficial ownership of the Private Placement Warrants as these
warrants are not exercisable within 60 days of the date of this Annual Report.
80
The beneficial ownership of
our ordinary shares is based on 28,750,000 Class A ordinary shares and 7,187,500 Class B ordinary shares as of March 9, 2026.
Before the Business Combination
Name and Address of Beneficial Owners
Number of
Class A
Ordinary
Shares (2)
Number of
Class B
Ordinary
Shares (3)
% of
Class A
Ordinary
Shares
% of
Class B
Ordinary
Shares
Directors and Executive Officers (1) :
Mohsin Y. Meghji
—
—
—
—
Thomas L. Fairfield
—
—
—
—
Benjamin Fader-Rattner
—
—
—
—
Edward D. Murphy
—
—
—
—
Paul W. Kopsky, Jr.
—
—
—
—
Franklin Liu Tsung
—
—
—
—
Robert Rivas (“Reeve”) Collins
—
—
—
—
Christopher Chaice
—
—
—
—
Charles H. F. Garner
—
—
—
—
Eric D. Greenhaus
—
—
—
—
Matthew Perkal
—
—
—
—
Chinh Chu
—
(4)
—
(4)
All Directors and Executive Officers as a group (12 individuals)
—
—
—
—
Greater than 5% Beneficial Owners:
MI7 Sponsor, LLC (the Sponsor) (5)
—
7,187,500
—
100 %
The Goldman Sachs Group, Inc. (6)
1,424,430
—
5.0 %
—
Polar Asset Management Partners Inc. (7)
1,757,441
—
6.1 %
—
Barclays PLC (8)
1,862,500
—
6.5 %
—
HGC Investment Management Inc (9)
1,500,000
—
5.2 %
—
Meteora Capital, LLC (10)
3,889,052
—
13.5 %
—
Cantor Fitzgerald & Co. (11)
7,779,865
—
27.1 %
—
Anson Funds Management LP (12)
2,860,625
—
9.9 %
—
Mizuho Financial Group, Inc. (13)
2,543,600
—
8.8 %
(1) Unless otherwise noted, the business address of each of the following is 1700 Broadway,
19 th Floor, New York, NY 10019.
(2) The reported number of Class A Ordinary Shares does not include Class A Ordinary
Shares that would be issued upon the conversion of Class B Ordinary Shares to Class A Ordinary Shares.
(3) The Class B Ordinary Shares can be converted into Class A Ordinary Shares on
a one-for-one basis.
(4) See footnote number 5 below for disclosures about ownership of entities affiliated with
Mr. Chu.
(5) The Sponsor directly holds the shares reported herein. If the Class B Ordinary Shares
were converted to Class A Ordinary Shares, Sponsor would directly hold 20% of the Class A Ordinary Shares outstanding. The
Sponsor Parent is the controlling member of the Sponsor. CC Capital Ventures LLC (“CC Ventures”) is the controlling member
of the Sponsor Parent and CC Capital SP, LP (“CC Capital SP”) is the sole member of CC Ventures. CC Capital GP, LLC (“CC Capital
GP”) is the general partner of CC Capital SP, and Mr. Chu is the sole member of CC Capital GP. Each of Mr. Chu,
CC Capital GP, CC Capital SP, CC Capital Ventures, and the Sponsor Parent may be deemed to beneficially own the Ordinary Shares
directly held by the Sponsor due to their relationships with the Sponsor. Each of the Sponsor Parent, CC Capital Ventures, CC Capital
SP, CC Capital GP and Chinh Chu disclaims beneficial ownership of the securities of the Issuer held directly by Sponsor except to the
extent of its or his pecuniary interest therein, directly or indirectly. The principal address of each of Sponsor, the Sponsor Parent,
CC Ventures, CC Capital SP, CC Capital GP, and Mr. Chu is 200 Park Avenue, 58 th Floor, New York, New York 10166.
81
(6) According to a Schedule 13G/A filed on November 14, 2025, by Goldman Sachs &
Co. LLC, a New York limited liability company, and The Goldman Sachs Group, Inc., a Delaware corporation. The principal address
of Goldman Sachs & Co. LLC and The Goldman Sachs Group, Inc. is 200 West Street, New York, NY 10282. The Goldman Sachs
Group Inc. is the parent holding company of Goldman Sachs & Co. LLC and Goldman Sachs & Co. LLC is a registered broker
or dealer and a registered investment advisor.
(7) According to a Schedule 13G/A filed on February 17, 2026, by (a) Polar Asset
Management Partners Inc., a company incorporated under the laws of Ontario, Canada, which serves as the investment advisor to Polar Multi-Strategy
Master Fund, a Cayman Islands exempted company (“PMSMF”) with respect to the shares held directly by PMSMF. The principal
business address for Polar Asset Management Partners Inc. is 16 York Street, Suite 2900, Toronto, Ontario, M5J 0E6.
(8) According to a Schedule 13G/A filed on March 21, 2025, by Barclays PLC. Barclays
PLC is the parent holding company of Barclays Bank PLC. The principal business address of Barclays PLC is 1 Churchill Place, London — E14
5HP.
(9) According to a Schedule 13G filed on February 14, 2025 by HGC Investment Management
Inc., a company incorporated under the laws of Canada, which serves as the investment manager to The HGC Fund LP, an Ontario limited
partnership, with respect to the Class A Ordinary Shares held by HGC Investment Management Inc. on behalf of The HGC Fund LP. The
principal business address of HGC Investment Management Inc. is 1027 Yonge St, Suite 301, Toronto, ON M4W 2K9.
(10) According to a Schedule 13G/A filed on January 27, 2026, by Meteora Capital, LLC, a Delaware
limited liability company (“Meteora Capital”). The address of the principal business office for Meteora Capital is: 1200
N Federal Hwy, #200, Boca Raton FL 33432.
(11) According to a Schedule 13D filed on December 19, 2025, by (a) Cantor Fitzgerald &
Co., a New York general partnership (“CF&Co.”), the record holder of the Class A Ordinary Shares, (ii) Cantor Fitzgerald
Securities, a New York general partnership (“CF Securities”), the direct holder of a majority of the equity interests of
CF&Co., (iii) Cantor Fitzgerald, L.P. , a Delaware limited partnership (“Cantor”), the indirect holder of a majority
of the equity interests of CF&Co. and CFS, (iv) CF Group Management, Inc., a New York corporation (“CFGM”), the managing
general partner of CFLP, and (v) Brandon G. Lutnick, a United States citizen (“Mr. Lutnick”), the Chairman and Chief Executive
Officer of CFLP and CFGM and also the trustee with decision making control of trusts that hold all of the voting shares of CFGM. As such,
each of CF Securities, Cantor, CFGM and Mr. Lutnick may be deemed to have beneficial ownership of the securities directly held by CF&Co.
Each such entity or person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest
they may have therein, directly or indirectly. The address of the principal place of business and principal office of Cantor, CF&Co.
and CF Securities is 110 East 59 th Street, New York, New York 10022, and the address of the principal place of business
and principal office of CFGM and the business address of Mr. Lutnick is 499 Park Avenue, New York, New York 10022.
(12) According to a Schedule 13G filed on December 8, 2025, by (a) Anson Funds Management LP,
a Texas limited partnership, (b) Anson Management GP LLC, a Texas limited liability company, (c) Tony Moore, a United States citizen
(d) Anson Advisors Inc., a company incorporated under the laws of Ontario, Canada, (e) Amin Nathoo, a Canadian citizen and (f) Moez Kassam,
a Canadian citizen. The principal business address of Anson Funds Management LP, Anson Management GP LLC and Mr. Moore is 16000 Dallas
Parkway, Suite 800 Dallas, Texas 75248. The principal business address for Anson Advisors Inc. Mr. Nathoo and Mr. Kassam is 181 Bay Street,
Suite 4200 Toronto, ON M5J 2T3.
(13) According to a Schedule 13G filed on February 12, 2026, by (a) Mizuho Financial Group,
Inc., a company incorporated under the laws of Japan, (b) Mizuho Bank, Ltd., (c) Mizuho Americas LLC, and (d) Mizuho Securities USA LLC.
The principal business address of Mizuho Financial Group, Inc. is 1-5-5, Otemachi, Chiyoda-ku, Tokyo, 100-8176, Japan.
82
Item 13. Certain Relationships and Related Transactions,
and Director Independence
Founder Shares
On March 15, 2024, our Original
Sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs in exchange for 7,178,500 founder shares.
On May 23, 2025, we entered
into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with the Original Sponsor and the Sponsor, pursuant
to which the Original Sponsor agreed to sell, and the Sponsor agreed to purchase, our 7,187,500 founder shares.
The
founder shares are identical to the Class A ordinary shares, except that:
● prior
to and/or in connection with the closing of our initial business combination, only holders
of the founder shares will be entitled to vote on the appointment and removal of directors
or continuing the Company in a jurisdiction outside the Cayman Islands (including any special
resolution required to amend the constitutional documents of the company or to adopt new
constitutional documents of the company, in each case, as a result of the company approving
a transfer by way of continuation in a jurisdiction outside the Cayman Islands);
● the
founder shares are subject to certain transfer restrictions, as described in more detail
below;
● the
founder shares are entitled to registration rights;
● the
founder shares are automatically convertible into our Class A ordinary shares in connection
with the consummation of our initial business combination or earlier at the option of the
holder on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights;
● the
Sponsor, and our officers and directors have entered into the Letter Agreement with us, pursuant
to which they have agreed to (i) waive their redemption rights with respect to their founder
shares and Public Shares in connection with the completion of our initial business combination
or an earlier redemption in connection with the commencement of the procedures to consummate
the initial business combination if we determine it is desirable to facilitate the completion
of the initial business combination; (ii) waive their redemption rights with respect to their
founder shares and Public Shares in connection with a shareholder vote to approve an amendment
to our amended and restated memorandum and articles of association (A) to modify the substance
or timing of our obligation to allow redemption in connection with our initial business combination
or to redeem 100% of our Public Shares if we have not consummated an initial business combination
within the completion window or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial business combination activity; (iii) waive their
rights to liquidating distributions from the Trust Account with respect to their founder
shares if we fail to complete our initial business combination within the completion window,
although they will be entitled to liquidating distributions from the Trust Account with respect
to any Public Shares they hold if we fail to complete our initial business combination within
the prescribed time frame and to liquidating distributions from assets outside the Trust
Account; and (iv) vote any founder shares held by them and any Public Shares purchased during
or after the IPO (including in open market and privately-negotiated transactions) in favor
of our initial business combination; and
● the
non-managing sponsor investors are not granted any shareholder or other rights in addition
to those afforded to our other public shareholders, and will only be issued membership interests
in our Sponsor, with no right to control our Sponsor or vote or dispose of any securities
held by our Sponsor, including the founder shares and the Private Placement Warrants held
by our Sponsor. The non-managing sponsor investors are not required to (i) hold any units,
Class A ordinary shares or public warrants they may have purchased in the IPO or thereafter
for any amount of time, (ii) vote any Class A ordinary shares they may own at the applicable
time in favor of our initial business combination or (iii) refrain from exercising their
right to redeem their public shares at the time of our initial business combination. The
non-managing sponsor investors will have the same rights to the funds held in the Trust Account
with respect to the Class A ordinary shares underlying the units they may have purchased
in the IPO or thereafter as the rights afforded to our other public shareholders.
The Company’s initial
shareholders have agreed, pursuant to lock-up provisions in the agreements entered into by our Sponsor and management team, not to transfer,
assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof until the earlier to occur of
(i) one year after the completion of the initial business combination or (ii) the date on which the Company completes a liquidation, merger,
share exchange or other similar transaction after the initial business combination that results in all of the Company’s shareholders
having the right to exchange their Class A ordinary shares for cash, securities or other property. Any permitted transferees will be subject
to the same restrictions and other agreements of the Company’s initial shareholders with respect to any founder shares (the “ Lock-up ”).
Notwithstanding the foregoing, if (1) the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted
for share sub-divisions, share capitalizations, share consolidations, reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after the initial business combination or (2) if the Company consummates
a transaction after the initial business combination which results in the Company’s shareholders having the right to exchange their
shares for cash, securities or other property, the founder shares will be released from the Lock-up.
83
Except in certain limited
circumstances, no member of our Sponsor (including the non-managing sponsor investors) may sell, transfer, assign, pledge, mortgage, charge,
hypothecate, exchange or otherwise dispose, directly or indirectly, of all or any portion of its membership interests in our Sponsor.
Private Placement Warrants
Our Sponsor and Cantor Fitzgerald
& Co., the representative of the underwriters, purchased an aggregate of 8,337,500 Private Placement Warrants for an aggregate purchase
price of $8,337,500 or $1.00 per warrant in a private placement that closed simultaneously with the closing of the IPO. Each Private Placement
Warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share.
Of those 8,337,500
Private Placement Warrants, the Original Sponsor purchased 5,043,750 Private Placement Warrants and Cantor Fitzgerald & Co. purchased
3,293,750 Private Placement Warrants. The non-managing sponsor investors purchased, indirectly through the purchase of non-managing sponsor
membership interests, an aggregate of 4,250,000 Private Placement Warrants at a price of $1.00 per warrant ($4,250,000 in the aggregate)
in a private placement that closed simultaneously with the closing of the IPO. In connection with each non-managing sponsor investor purchasing,
through our Original Sponsor, the Private Placement Warrants allocated to it in connection with the closing of the IPO, our Original Sponsor
issued membership interests at a nominal purchase price to the non-managing sponsor investors reflecting interests in an aggregate of
3,400,000 founder shares held by our Original Sponsor.
On May 23, 2025, the Original
Sponsor sold 5,043,750 of our Private Placement Warrants to the Sponsor, pursuant to the terms of the Securities Purchase Agreement.
Also on May 27, 2025, the
Sponsor entered into an agreement to purchase the 3,293,750 Private Placement Warrants of the Company held by Cantor Fitzgerald &
Co.
The Private
Placement Warrants are identical to the warrants sold in the IPO except that, so long as they are held by our Sponsor or its permitted
transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these warrants),
subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial
business combination and (ii) will be entitled to registration rights.
Related Party Loans
Prior to the IPO, we issued
a promissory note to the Original Sponsor, pursuant to which we could borrow up to an aggregate principal amount of $300,000 (the “ Promissory
Note ”). The Promissory Note was non-interest bearing and payable upon the earlier of (i) December 31, 2024 or (ii) the completion
of the IPO. No amounts were borrowed under the Promissory Note and borrowings under the Promissory Note are not longer available.
On June 16, 2025, we issued
a promissory note, pursuant to which we could borrow up to an aggregate principal amount of $2,500,000 from the Sponsor (the “ Sponsor
Note ”). As of December 31, 2025, the full $2,500,000 available under the Sponsor Note had been drawn, and the entire amount
was outstanding. Up to $1,500,000 of the aggregate principal amount drawn under the Sponsor Note may be convertible into Private Placement
Warrants of the post business combination entity at a price of $1.00 per warrant at the option of the Sponsor. If the Business Combination
or another initial business combination is not consummated, the Sponsor Note may not be repaid and may not be able to be converted into
Pubco Warrants, pursuant to its terms. Such warrants would be identical to the Private Placement Warrants.
On February 18, 2026, we
issued a promissory note (the “ Second Sponsor Note ”) to the Sponsor, pursuant to which we can borrow up to an aggregate
principal amount of $2,000,000 from the Sponsor. On February 18, 2026, we borrowed $600,000 under the Second Sponsor Note. The proceeds
of the Second Sponsor Note will be used for general working capital purposes. The Second Sponsor Note bears no interest and is payable
in full upon the consummation of our initial business combination. If the Business Combination or another initial business combination
is not consummated, the Second Sponsor Note may not be repaid, pursuant to its terms.
In addition, in order to finance
transaction costs in connection with an intended initial business combination, the Sponsor or an affiliate of the Sponsor or certain of
our officers and directors may, but are not obligated to (except in the case of the committed Sponsor loans), loan us funds as may be
required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business
combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but
no proceeds from our Trust Account would be used to repay such loaned amounts. Prior to the completion of our initial business combination,
we do not expect to seek loans from parties other than the Sponsor or an affiliate of the Sponsor as we do not believe third parties will
be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.
84
Item 14 . Principal Accountant Fees and
Services.
The firm of WithumSmith+Brown,
PC, or Withum, acts as our independent registered public accounting firm. The following is a summary of fees paid to Withum for services
rendered.
Audit Fees . For the
year ended December 31, 2025, fees for our independent registered public accounting firm were approximately $138,840 for the services
Withum performed in connection with the audit of our December 31, 2025 financial statements included in this Annual Report on Form 10-K.
During the period from March 12, 2024 (inception) through December 31, 2024, fees for our independent registered public accounting firm
were approximately $114,000 for the services Withum performed in connection with our IPO and the audit of our December 31, 2024 financial
statements included in this Annual Report on Form 10-K.
Audit-Related Fees.
During the year ended December 31, 2025, and the period from March 12, 2024 (inception) through December 31, 2024, our independent registered
public accounting firm did not render assurance and related services related to the performance of the audit or review of financial statements.
Tax Fees . During the
year ended December 31, 2025, and the period from March 12, 2024 (inception) through December 31, 2024, our independent registered public
accounting firm did not render services to us for tax compliance, tax advice and tax planning.
All Other Fees . During
the year ended December 31, 2025, and the period from March 12, 2024 (inception) through December 31, 2024, there were no fees billed
for products and services provided by our independent registered public accounting firm other than those set forth above.
Pre-Approval Policy
Since the formation of our
audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit
services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit
services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
85
PART IV
Item 15 . Exhibits, Financial Statement
Schedules.
(a) The following documents are filed
as part of this Form 10-K:
(1) Financial Statements:
Report of Independent Registered Public Accounting Firm PCAOB ID Number 100
F-2
Financial Statements:
Balance Sheets as of December 31, 2025 and 2024
F-3
Statements of Operations for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-4
Statements of Changes in Shareholders’ Deficit for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-5
Statements of Cash Flows for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-6
Notes to Financial Statements
F-7 to F-24
(2) Financial Statement Schedules:
All schedules are omitted for the reason that the
information is included in the financial statements or the notes thereto or that they are not required or are not applicable.
(3) Exhibits:
The exhibits listed in the Exhibit Index below
are filed or incorporated by reference as part of this Annual Report on Form 10-K.
Exhibit
Number
Description
1.1
Underwriting
Agreement, dated July 31, 2024, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters
(incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the
Securities and Exchange Commission on August 6, 2024).
2.1
Business
Combination Agreement, dated as of July 7, 2025, by and among the Company, ReserveOne, Pubco, SPAC Merger Sub and Company Merger
Sub. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 8, 2025).
3.1
Amended
and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Company’s Current Report
on Form 8-K (File No. 001-42171), filed with the Securities and Exchange Commission on August 6, 2024).
4.1
Specimen
Unit Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 3 to the Registration Statement on Form S-1 (File No.
333-279951), filed with the SEC on July 18, 2024).
4.2
Specimen
Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Registration Statement on Form S-1
(File No. 333-279951), filed with the SEC on June 21, 2024).
4.3
Specimen
Warrant Certificate (incorporated by reference to Exhibit 4.3 to Amendment No. 1 to the Registration Statement on Form S-1 (File
No. 333-279951), filed with the SEC on June 21, 2024).
4.4
Warrant
Agreement, dated July 31, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated
by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the Securities and
Exchange Commission on August 6, 2024).
4.5
Description
of Registrant’s Securities (incorporated by reference to Exhibit 4.5 to the Company’s Annual Report on Form 10-K (File
No. 001-42171), filed with the Securities and Exchange Commission on March 28, 2025).
10.1
Letter
Agreement, dated July 31, 2024, among the Company, its executive officers, its directors and M3-Brigade Sponsor V LP (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the Securities and
Exchange Commission on August 6, 2024).
10.2
Investment
Management Trust Agreement, dated July 31, 2024, between the Company and Continental Stock Transfer & Trust Company, as trustee
(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the
Securities and Exchange Commission on August 6, 2024).
10.3
Registration
Rights Agreement, dated July 31, 2024, among the Company, M3-Brigade Sponsor V LP and the Holders signatory thereto (incorporated
by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the Securities and
Exchange Commission on August 6, 2024).
10.4
Private
Placement Warrants Purchase Agreement, dated July 31, 2024, between the Company and M3-Brigade Sponsor V LP (incorporated by reference
to Exhibit 10.4 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the Securities and Exchange Commission
on August 6, 2024).
86
Exhibit
Number
Description
10.5
Private
Placement Warrants Purchase Agreement, dated July 31, 2024, between the Company and Cantor, Fitzgerald & Co. (incorporated by
reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K (File No. 001-42171), filed with the Securities and Exchange
Commission on August 6, 2024).
10.6
Promissory
Note issued to M3-Brigade Sponsor V LLC (formerly M3-Brigade Sponsor V LP) (incorporated by reference to Exhibit 10.7 to the Registration
Statement on Form S-1 (File. No. 333-279951), filed with the SEC on June 5, 2024).
10.7
Securities
Subscription Agreement between the Company and M3-Brigade Sponsor V LLC (formerly M3-Brigade Sponsor V LP) (incorporated by reference
to Exhibit 10.8 to the Registration Statement on Form S-1 (File. No. 333-279951), filed with the SEC on June 5, 2024).
10.8
Securities
Purchase Agreement, dated as of May 23, 2025, by and among M3-Brigade Acquisition V Corp., M3-Brigade Sponsor V LLC and MI7 Sponsor,
LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange
Commission on May 27, 2025).
10.9
Limited
Waiver, dated as of May 27, 2025, by and among M3-Brigade Acquisition V Corp., M3-Brigade Sponsor V LLC, and MI7 Sponsor, LLC, Cantor
Fitzgerald & Co. and other parties thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K, filed with the Securities and Exchange Commission on May 27, 2025).
10.10
Assignment
and Assumption Agreement, dated as of May 27, 2025, by and among M3-Brigade Acquisition V Corp., M3-Brigade Sponsor V LLC, and MI7
Sponsor, LLC, Cantor Fitzgerald & Co. and the other parties thereto (incorporated by reference to Exhibit 10.3 to the Company’s
Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 27, 2025).
10.11
Letter
Agreement Assignment Agreement, dated as of May 27, 2025, by and among M3-Brigade Acquisition V Corp., M3-Brigade Sponsor V LLC,
and MI7 Sponsor, LLC and other parties thereto (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on
Form 8-K, filed with the Securities and Exchange Commission on May 27, 2025).
10.12
Form
of Indemnity Agreement (incorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1/A (File
No. 333-279951), filed with the Securities and Exchange Commission on June 21, 2024).
10.13
Promissory
Note dated June 16, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with
the Securities and Exchange Commission on June 18, 2025).
10.14
First Amendment to Promissory Note dated July 16, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 18, 2025).
10.15
Sponsor
Support Agreement, dated as of July 7, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.1
to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 8, 2025).
10.16
Form
of Lock-Up Agreement by and between the Sponsor Parent and Pubco (incorporated by reference to Exhibit 10.2 to the Company’s
Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 8, 2025).
10.17
Form
of Equity PIPE Subscription Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K,
filed with the Securities and Exchange Commission on July 8, 2025) .
10.18
Form of Convertible Notes Subscription Agreement (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 8, 2025).
10.19
Promissory Note dated February 18, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 18, 2026).
10.20*
M3-Brigade Acquisition V Corp. Non-Employee Director Compensation Plan
14.1
Code
of Ethics (incorporated by reference to Exhibit 14.1 to Amendment No. 1 to the Registration Statement on Form S-1 (File. No. 333-279951),
filed with the SEC on June 21, 2024).
19.1
Securities Trading Policy of the Company (incorporated by reference to Exhibit 19.1 to the Company’s Annual Report Form 10-K, filed with the Securities and Exchange Commission on March 28, 2025).
24.1*
Power of Attorney (included in the signature page of this Annual Report)
31.1*
Certification of the Chief Executive Officer required by Rule 13a-14(a)
or Rule 15d-14(a).
31.2*
Certification of the Chief Financial Officer required by Rule 13a-14(a)
or Rule 15d-14(a).
32.1**
Certification of the Chief Executive Officer required by Rule 13a-14(b)
or Rule 15d-14(b) and 18 U.S.C. 1350.
32.2**
Certification of the Chief Financial Officer required by Rule 13a-14(b)
or Rule 15d-14(b) and 18 U.S.C. 1350.
97.1
Policy relating to recovery of erroneously awarded compensation, as required by applicable listing standards adopted pursuant to 17 CFR 240.10D-1 (incorporated by reference to Exhibit 97.1 to the Company’s Annual Report Form 10-K, filed with the Securities and Exchange Commission on March 28, 2025).
101.INS
Inline XBRL Instance Document (the instance document does not appear
in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained
in Exhibit 101)
* Filed herewith
** Furnished herewith
87
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly cause this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date: March 12, 2026
M3-Brigade Acquisition V Corp.
By:
/s/ Mohsin Y. Meghji
Name:
Mohsin Y. Meghji
Title:
Executive Chairman of the Board
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE
PRESENTS, that each person whose signature appears below constitutes and appoints Mohsin Y. Meghji and Charles Garner, his true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all
capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in
connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents, or any of them, or his or her substitutes or substitute, may lawfully do or cause to be done by
virtue hereof.
Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.
Signature
Title
Date
/s/ Robert Rivas Collins
Chief Executive Officer
March 12, 2026
Robert Rivas Collins
(Principal Executive Officer)
/s/ Eric Greenhaus
Chief Financial Officer
March 12, 2026
Eric Greenhaus
(Principal Financial Officer and Accounting Officer)
/s/ Mohsin Y. Meghji
Chairman of the Board of Directors
March 12, 2026
Mohsin Y. Meghji
/s/ Matthew Perkal
Chief Operating Officer and Director
March 12, 2026
Matthew Perkal
/s/ Chinh Chu
President
March 12, 2026
Chinh Chu
/s/ Chris Chaice
Executive Vice President
March 12, 2026
Chris Chaice
/s/ Charles Garner
Executive Vice President and Secretary
March 12, 2026
Charles Garner
/s/ Benjamin Fader-Rattner
Director
March 12, 2026
Benjamin Fader-Rattner
/s/ Thomas Fairfield
Director
March 12, 2026
Thomas Fairfield
/s/ Edward Murphy
Director
March 12, 2026
Edward Murphy
/s/ Paul Kopsky
Director
March 12, 2026
Paul Kopsky
/s/ Franklin Tsung
Director
March 12, 2026
Franklin Tsung
88
M3-BRIGADE ACQUISITION V CORP.
INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm PCAOB ID Number 100
F-2
Financial Statements:
Balance Sheets as of December 31, 2025 and 2024
F-3
Statements of Operations for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-4
Statements of Changes in Shareholders’ Deficit for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-5
Statements of Cash Flows for the year ended December 31, 2025 and for the Period from March 12, 2024 (inception) through December 31, 2024
F-6
Notes to Financial Statements
F-7 to F-24
F- 1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
M3-Brigade Acquisition V Corp.:
Opinion on the Financial Statements
We have audited the accompanying balance sheets of M3-Brigade Acquisition V Corp. as of December 31, 2025 and 2024, and the related statements of operations, changes in shareholders’ deficit and cash flow for the year ended December 31, 2025 and for the period March 12, 2025 (inception) through December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of M3-Brigade Acquisition V Corp. as of December 31, 2025 and 2024, and the results of its operations and its cash flows for the year ended December 31, 2025 and for the period March 12, 2025 (inception) through December 31, 2024, in conformity with the accounting principles generally accepted in the United States of America.
Substantial Doubt about the Company’s Ability to Continue as a Going Concern
The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company’s liquidity condition and mandatory liquidation date raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regards to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on the entity’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to M3-Brigade Acquisition V Corp. in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. M3-Brigade Acquisition V Corp. is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/S/ WithumSmith+Brown PC
We have served as M3-Brigade Acquisition V Corp.'s auditor since 2024.
New York, New York
March 12, 2026
PCAOB number 100
F- 2
M3-BRIGADE ACQUISITION V CORP.
BALANCE SHEET
December 31,
2025
December 31,
2024
Assets:
Current assets
Cash $ 1,175,051 $ 821,188
Prepaid expenses, current 124,844 210,845
Due from related party 527 —
Other assets — 41,250
Total current assets 1,300,422 1,073,283
Long-term prepaid expense — 119,010
Investments held in Trust Account 306,880,908 294,617,243
Total Assets $ 308,181,330 $ 295,809,536
Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
Current liabilities
Accrued offering costs $ — $ 250,000
Accrued expenses 4,796,309 98,948
Convertible promissory note – related party 2,500,000 —
Advances from related party — 378,757
Total current liabilities 7,296,309 727,705
Deferred underwriting fee payable 13,400,000 13,400,000
Total Liabilities 20,696,309 14,127,705
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value of approximately $ 10.67 and $ 10.25 per share as of December 31, 2025 and 2024, respectively 306,880,908 294,617,243
Shareholders’ Deficit
Preferred shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of December 31, 2025 and 2024 — —
Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued or outstanding (excluding 28,750,000 shares subject to possible redemption) as of December 31, 2025 and 2024 — —
Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 7,187,500 shares issued and outstanding as of December 31, 2025 and 2024 719 719
Additional paid-in capital — —
Accumulated deficit ( 19,396,606 ) ( 12,936,131 )
Total Shareholders’ Deficit ( 19,395,887 ) ( 12,935,412 )
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit $ 308,181,330 $ 295,809,536
The accompanying notes are an integral part of
the financial statements.
F- 3
M3-BRIGADE ACQUISITION V CORP.
STATEMENTS OF OPERATIONS
For the Year Ended
December 31,
2025
For the
Period from
March 12,
2024
(Inception)
Through
December 31,
2024
General and operating costs $ 6,484,916 $ 453,416
Loss from operations ( 6,484,916 ) ( 453,416 )
Other (expense) income:
Interest earned on investments held in Trust Account 12,263,666 5,679,743
Total other income, net 12,263,666 5,679,743
NET INCOME $ 5,778,750 $ 5,226,327
Weighted average shares outstanding of Class A ordinary shares 28,750,000 14,813,559
Basic and diluted net income per ordinary share, Class A ordinary shares $ 0.16 $ 0.24
Weighted average shares outstanding of Class B ordinary shares 7,187,500 6,733,051
Basic net income per ordinary share, Class B ordinary shares $ 0.16 $ 0.24
Weighted average shares outstanding of Class B ordinary shares 7,187,500 7,187,500
Diluted net income per ordinary share, Class B ordinary shares $ 0.16 $ 0.24
The accompanying notes are an integral part of
the financial statements.
F- 4
M3-BRIGADE ACQUISITION V CORP.
STATEMENTS OF CHANGES IN SHAREHOLDERS’
DEFICIT
FOR THE YEAR ENDED DECEMBER 31, 2025 AND
FOR THE PERIOD FROM MARCH 12, 2024 (INCEPTION)
THROUGH DECEMBER 31, 2024
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional
Paid-in
Accumulated
Total
Shareholders’
Shares
Amount
Shares
Amount
Capital
Deficit
Deficit
Balance – March 12, 2024 (inception) — $ — — $ — $ — $ — $ —
Issuance of Class B ordinary shares to Sponsor — — 7,187,500 719 24,281 — 25,000
Accretion for Class A ordinary shares to redemption amount — — — — ( 11,524,046 ) ( 18,162,458 ) ( 29,686,504 )
Sale of 8,337,500 Private Placement Warrants — — — — 8,337,500 — 8,337,500
Fair value of Public Warrants at issuance — — — — 3,421,250 — 3,421,250
Allocated value of transaction costs to Class A shares — — — — ( 258,985 ) — ( 258,985 )
Net income — — — — — 5,226,327 5,226,327
Balance – December 31, 2024 — — 7,187,500 719 — ( 12,936,131 ) ( 12,935,412 )
Former Sponsor Contribution — — — — 24,440 — 24,440
Accretion for Class A ordinary shares to redemption amount — — — — ( 24,440 ) ( 12,239,225 ) ( 12,263,665 )
Net income — — — — — 5,778,750 5,778,750
Balance – December 31, 2025 — $ — 7,187,500 $ 719 $ — $ ( 19,396,606 ) $ ( 19,395,887 )
The accompanying notes are an integral part of
the financial statements.
F- 5
M3-BRIGADE ACQUISITION V CORP.
STATEMENTS OF CASH FLOWS
For the Year Ended
December 31,
2025
For the
Period from
March 12,
2024
(Inception)
Through
December 31,
2024
Cash Flows from Operating Activities:
Net income $ 5,778,750 $ 5,226,327
Adjustments to reconcile net income to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares — 5,454
Payment of operation costs through promissory note 51,898 —
Payment of operation costs through advance from related party 24,440 142,233
Interest earned on investments held in Trust Account ( 12,263,666 ) ( 5,679,743 )
Changes in operating assets and liabilities:
Other assets 41,250 ( 41,250 )
Prepaid expenses 205,012 ( 254,856 )
Due from related party ( 527 ) —
Accrued expenses 4,697,361 98,948
Net cash used in operating activities ( 1,465,482 ) ( 502,887 )
Cash Flows from Investing Activities:
Investment of cash into Trust Account — ( 288,937,500 )
Net cash used in investing activities — ( 288,937,500 )
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid — 282,500,000
Proceeds from sale of Private Placements Warrants — 8,337,500
Payment of offering costs ( 250,000 ) ( 575,925 )
Repayment of advances from related party ( 430,655 ) —
Proceeds from promissory note – related party 2,500,000 —
Net cash provided by financing activities 1,819,345 290,261,575
Net Change in Cash 353,863 821,188
Cash – Beginning of period 821,188 —
Cash – End of period $ 1,175,051 $ 821,188
Noncash investing and financing activities:
Capital contribution from Original Sponsor $ 24,440 $ —
Offering costs included in accrued offering costs $ — $ 250,000
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares $ — $ 19,546
Deferred offering cost paid through advance from related party $ — $ 161,525
Prepaid expenses paid by advance from related party $ — $ 75,000
Deferred underwriting fee payable $ — $ 13,400,000
The accompanying notes are an integral part of
the financial statements.
F- 6
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
M3-Brigade Acquisition V Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted corporation on March 12, 2024 . The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
As of December 31, 2025, the Company had not commenced any operations. All activity for the period from March 12, 2024 (inception) through December 31, 2025 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and the search for a Business Combination, which is described below and in Note 6. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s Initial Public Offering was declared effective on July 31, 2024. On August 2, 2024, the Company consummated the Initial Public Offering of 28,750,000 units (the “Units”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,750,000 Units, at $ 10.00 per Unit, generating gross proceeds of $ 287,500,000 , which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 8,337,500 warrants (the “Private Placement Warrants”) to the Original Sponsor (as defined below) and Cantor Fitzgerald & Co. at a price of $ 1.00 per warrant, or $ 8,337,500 , which is described in Note 4 (the “Private Placement”). Of those 8,337,500 Private Placement Warrants, the Original Sponsor purchased 5,043,750 Private Placement Warrants and Cantor Fitzgerald & Co. purchased 3,293,750 Private Placement Warrants. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share. Certain institutional investors who are not affiliated with any member of management, the Original Sponsor or any other investor in the Original Sponsor provided approximately 50.1 % of the capital utilized by the Original Sponsor to purchase the Private Placement Warrants and, as a result, indirectly hold approximately 50.1 % of such warrants.
Transaction costs relating to the Initial Public Offering amounted to $ 19,406,996 , consisting of $ 5,000,000 of cash underwriting fees, $ 13,400,000 of deferred underwriting fees (see additional discussion in Note 6), and $ 1,006,996 of other offering costs.
The Company’s former sponsor is M3-Brigade Sponsor V LLC, a Delaware limited liability company (the “Original Sponsor”), formerly known as M3-Brigade Sponsor V LP, a Delaware limited partnership. On May 23, 2025, the Original Sponsor and MI7 Sponsor, LLC, a Delaware limited liability company (the “Sponsor”) and the Company (only for the purposes of facilitating the purchase and share transfer) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”), pursuant to which the Original Sponsor agreed to sell, and the Sponsor agreed to purchase, 7,187,500 Class B ordinary shares, par value $ 0.0001 per share, and 5,043,750 Private Placement Warrants of the Company owned by the Original Sponsor (collectively, the “Transferred Sponsor SPAC Securities”) for an aggregate purchase price of $ 6,467,500 (the “Closing Cash Purchase Price”). The transactions contemplated by the Securities Purchase Agreement were consummated on May 27, 2025 (the “Closing”). At the Closing, the Original Sponsor delivered to the Sponsor an assignment of the Transferred Sponsor SPAC Securities against payment of the Closing Cash Purchase Price.
Also on May 27, 2025, the Sponsor entered into an agreement to purchase 3,293,750 additional Private Placement Warrants of the Company from Cantor Fitzgerald & Co. (the “Cantor Warrants”) for an aggregate purchase price of $ 10 , which was consummated on May 27, 2025, upon which Cantor Fitzgerald & Co. delivered to the Sponsor an assignment of the Cantor Warrants.
The Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80 % of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the interest earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50 % or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the ”Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.
F- 7
Following the closing of the Initial Public Offering, on August 2, 2024, an amount of $ 288,937,500 ($ 10.05 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants was placed in the trust account (the “Trust Account”), which may only be held as cash or invested in (i) U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations or (ii) an interest bearing bank demand deposit account or other accounts at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering or by such earlier liquidation date as the board of directors may approve (the “Completion Window”), subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100 % of the Company’s public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.
The Company will provide the Company’s public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding public shares, subject to the limitations. The amount initially placed in the Trust Account upon the closing of the Initial Public Offering was $ 10.05 per public share.
The ordinary shares subject to redemption were recorded at their redemption value and classified as temporary equity upon the completion of the Initial Public Offering on August 2, 2024, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In the event the Company seeks shareholder approval for the Business Combination, the transaction would require a majority of the issued and outstanding shares voted to be in favor of the Business Combination.
The Company will have only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will cease all operations except for the purpose of winding up and, as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the public shares and completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law.
The Original Sponsor, officers and directors have entered into a letter agreement (the “Letter Agreement”) with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its Initial Business Combination or to redeem 100 % of the Company’s public shares if it has not consummated an Initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination.
F- 8
Pursuant to the Letter Agreement, the Original Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company (except for the Company’s independent auditors), or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement (except for the Company’s independent auditors), reduce the amount of funds in the Trust Account to below the lesser of (i) $ 10.05 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $ 10.05 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Original Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Original Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Original Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Original Sponsor would be able to satisfy those obligations.
Pursuant to the Securities Purchase Agreement, on May 27, 2025, the Company entered into an Assignment and Assumption Agreement with the Sponsor, the Original Sponsor and the Company’s directors and executive officers, pursuant to which the Original Sponsor assigned to the Sponsor, and the Sponsor assumed, all of the Original Sponsor’s rights, title and interests under the Letter Agreement, and the Sponsor agreed to be bound by all terms, conditions, and covenants and be entitled to all the terms and provisions therein.
Proposed Business Combination
Business Combination Agreement
On July 7, 2025, the Company, ReserveOne, Inc., a Delaware corporation (“ReserveOne”), ReserveOne Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of ReserveOne (“Pubco”), R1 SPAC Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“SPAC Merger Sub”), and R1 Company Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“Company Merger Sub” and, together with the SPAC Merger Sub, the “Merger Subs”), entered into a business combination agreement (the “Business Combination Agreement”).
As a result of the transactions contemplated by the Business Combination Agreement, the Company will be de-registered in the Cayman Islands and register by way of continuation to the State of Delaware and domesticate as a Delaware corporation (the “Domestication”).
Following the Domestication, SPAC Merger Sub will merge with and into the Company (the “SPAC Merger”), with the Company continuing as the surviving entity (the “SPAC Surviving Subsidiary”), and as a result of which the Company will be a wholly-owned subsidiary of Pubco. Promptly following the SPAC Merger, Company Merger Sub will merge with and into ReserveOne (the “Company Merger” and, together with the SPAC Merger, the “Mergers”), with ReserveOne continuing as the surviving company (the “Company Surviving Subsidiary”), and as a result of which ReserveOne will be a wholly-owned subsidiary of Pubco.
As a result of the Mergers, Pubco will become a publicly traded company, all upon the terms and subject to the conditions set forth in the Business Combination Agreement and in accordance with applicable laws.
The shares of Pubco Class A common stock, par value $ 0.0001 per share, will be listed for trading and will be freely transferable, subject to the transfer restrictions set forth in the sponsor support agreement entered into by the Company, Pubco and the Sponsor in connection with the Business Combination (the “Sponsor Support Agreement”) and the lock-up agreement to be entered into by Pubco, the parent company of the Sponsor, CC MI7 SPV, LLC (the “Sponsor Parent”) and MI7 Founders, LLC (“MI7 Holder”)(the “Lock-Up Agreement”) and any restrictions pursuant to applicable laws. The shares of Pubco Class B common stock, par value $ 0.0001 per share, will not be listed or freely transferable.
The Closing is expected to occur in the second quarter of 2026, subject to the satisfaction of certain customary closing conditions.
F- 9
Equity PIPE Subscription Agreement
Contemporaneously with the execution of the Business Combination Agreement, on July 7, 2025, certain investors (the “Equity PIPE Investors”) entered into subscription agreements (collectively, the “Equity PIPE Subscription Agreements”) with ReserveOne, Pubco, and solely with respect to Section 8(u) thereof, the Company, pursuant to which the Equity PIPE Investors agreed to purchase up to an aggregate of $ 500,000,000 of (a) either (i) ReserveOne Common Shares or (ii) in the event the issuance of ReserveOne Common Shares would, in the opinion of the Company, ReserveOne or Pubco on the advice of any of their respective legal counsel, adversely affect the treatment of the Transactions under Section 351 of the Internal Revenue Code of 1986 (the “Code”), shares Pubco Class A common stock (the “Equity PIPE Shares”) and (b) either (i) ReserveOne Warrants or (ii) in the event the issuance of ReserveOne Warrants would, in the opinion of the Company, ReserveOne or Pubco and on the advice of their respective legal counsel, adversely affect the treatment of the Transactions under Section 351 of the Internal Revenue Code of 1986, Pubco Warrants (“PIPE Warrants” and, together with the Equity PIPE Shares, the “Equity PIPE Securities”) at an aggregate purchase price of $ 10.00 , which $ 10.00 will entitle Equity PIPE Investors to one Equity PIPE Share and one PIPE Warrant, in a private placement (the “Equity PIPE”). The PIPE Warrants (and the shares underlying the PIPE Warrants, the “Warrant Shares”) will be issued pursuant to a Warrant Agreement by and among ReserveOne, Pubco and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”). The Equity PIPE Investors are permitted, under the Equity PIPE Subscription Agreements, to satisfy their commitments thereunder if they hold Company Class A ordinary shares that qualify as Non-Redeemed Shares (as defined in the PIPE Subscription Agreement) by delivering written notice to the Company of its election to fulfill its commitment thereby, subject to certain conditions and restrictions set forth in the Equity PIPE Subscription Agreements. The purchase price for the Equity PIPE Securities may be paid in either cash or Bitcoin, at the sole election of each of the Equity PIPE Investors.
The net proceeds of the Equity PIPE will be converted into Bitcoin, subject to the terms of the Business Combination Agreement (after giving effect to any exceptions therein with respect to payment of any operating expenses and the payment of any expenses related to the consummation of the Business Combination).
The closing of the Equity PIPE is contingent upon the satisfaction of all closing conditions to consummate the Transactions and the Equity PIPE Investors’ consent to any amendments, modifications or waivers to the terms of the Business Combination Agreement that would reasonably be expected to materially and adversely affect the economic benefits of the Equity PIPE Investors, among other customary closing conditions.
Pursuant to the Equity PIPE Subscription Agreements, the Company and Pubco have agreed to use commercially reasonable efforts to cause the Equity PIPE Securities and Warrant Shares to be registered on the Registration Statement. To the extent that any Equity PIPE Securities and Warrant Shares are unable to be included on the Registration Statement, Pubco has agreed to register and maintain the registration of the Equity PIPE Securities and Warrant Shares by filing a resale registration statement with the SEC within 30 calendar days after the Closing (at Pubco’s sole cost and expense), to register the resale of the Equity PIPE Securities and Warrant Shares. Pubco has agreed to use its commercially reasonable efforts to have such resale registration statement declared effective as soon as practicable after the filing thereof, but no later than 60 calendar days after the Closing, which may be extended an additional 30 calendar days depending on whether the SEC issues comments on the resale registration statement.
Each Equity PIPE Subscription Agreement will terminate and be void and of no further force and effect, subject to certain exceptions, upon the earliest to occur of (i) such date and time as the Business Combination Agreement is terminated in accordance with its terms; (ii) the mutual written agreement of the respective parties to terminate such agreement; or (iii) July 7, 2026.
Convertible Note Subscription Agreement
Contemporaneously with the execution of the Business Combination Agreement, on July 7, 2025, certain investors entered into subscription agreements (the “Convertible Notes Subscription Agreements” and such investors, the “Convertible Notes Investors”) with Pubco, and, solely with respect to Section 9(t) thereof, the Company, pursuant to which the Convertible Notes Investors have agreed to purchase up to $ 250,000,000 in aggregate principal amount of Pubco’s 1.00 % Convertible Senior Notes (the “Convertible Notes” and such subscriptions, including the purchase of any Option Convertible Notes (as defined below), the “Convertible Notes PIPE,” and together with the Equity PIPE, the “PIPE Investments”), upon the terms and subject to the conditions set forth therein. In addition, for a period of 30 days following the execution of the Convertible Notes Subscription Agreements, Pubco granted the Convertible Notes Investors an option to purchase additional convertible notes in an aggregate principal amount of up to $ 50 million, on a pro rata basis based on such Convertible Notes Investor’s subscription for Initial Convertible Notes (the “Option Convertible Notes”). None of the Convertible Notes Investors exercised their option to purchase the Option Convertible Notes.
The net proceeds of the Convertible Notes PIPE will be converted into Bitcoin.
The closing of the Convertible Notes PIPE is contingent upon the satisfaction of all closing conditions to consummate the Transactions and the Convertible Notes Investors’ consent to any amendments, modifications or waivers to the terms of the Business Combination Agreement that would reasonably be expected to materially and adversely affect the economic benefits of the Convertible Notes Investors, among other customary closing conditions.
Pursuant to the Convertible Notes Subscription Agreements, Pubco has agreed to register and maintain the registration of the Pubco Class A Common Shares issuable upon conversion of the Convertible Notes by filing a resale registration statement with the SEC within 30 calendar days after the Closing (at Pubco’s sole cost and expense), to register the resale of the Pubco Class A Common Shares. Pubco has agreed to use its commercially reasonable efforts to have such resale registration statement declared effective as soon as practicable after the filing thereof, but no later than 60 calendar days after the Closing, which may be extended an additional 30 calendar days depending on whether the SEC issues comments on the resale registration statement.
F- 10
Amended and Restated Registration Rights Agreement
Concurrently with the consummation of the transactions contemplated by the Business Combination Agreement, the Company, Pubco, the Sponsor, the Sponsor Parent and the MI7 Holder will enter into a registration rights agreement that will amend and restate the current registration rights agreement entered into at the time of the Company’s initial public offering between the Company and the Original Sponsor (the “Amended and Restated Registration Rights Agreement”), pursuant to which Pubco will (i) assume the registration obligations of the Company under such registration rights agreement and (ii) provide registration rights with respect to the resale of the Registrable Securities (as defined the Amended and Restated Registration Rights Agreement) held by the Sponsor, the Sponsor Parent and the MI7 Holder.
Going Concern, Liquidity and Capital Resources
As of December 31, 2025, the Company had $ 1,175,051 in cash and working capital deficit of $ 5,995,887 . In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements - Going Concern,” management has determined that the Company’s liquidity concerns and mandatory liquidation date raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The Company cannot assure that its plans to consummate an Initial Business Combination will be successful.
On June 16, 2025, the Company issued a promissory note (the “Note”) to the Sponsor, pursuant to which the Company can borrow up to an aggregate principal amount of $ 2,500,000 from the Sponsor. The Note bears no interest and is payable in full upon the consummation of the Company’s initial business combination (the “Maturity Date”). A failure to pay the principal on the Maturity Date shall be deemed an event of default, in which case the Note may be accelerated. If the Company does not consummate an initial business combination, the Note will be repaid solely to the extent the Company has funds available outside its trust account established in connection with the Company’s initial public offering. On June 18, 2025, September 19, 2025 and December 22, 2025, the Company borrowed $ 500,000 , $ 1,500,000 and $ 500,000 , respectively, under the Note.
On July 16, 2025, the Company and the Sponsor entered into the First Amendment to the Note (the “Note Amendment”), solely to correct a scrivener’s error regarding the Sponsor’s option to convert up to $ 1,500,000 of the outstanding unpaid principal balance under the Note into Private Placement Warrants at a purchase price of $ 1.50 per Private Placement Warrant. Pursuant to the Note Amendment, the purchase price per Private Placement Warrant was corrected to reflect a purchase price of $ 1.00 per Private Placement Warrant upon conversion under the Note. All other terms of the Note remain unchanged.
The Company may need to raise additional funds, other than any potential borrowings under the Note, in order to fund the expenditures required for operating its business. However, if the estimate of the costs of completing the transactions contemplated by the agreement with respect to an initial Business Combination discussed in Note 6 are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the completion of a Business Combination.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
F- 11
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $ 1,175,051 and $ 821,188 in cash as of December 31, 2025 and 2024, respectively. The Company had no cash equivalents as of December 31, 2025 and 2024.
Investments Held in Trust Account
At December 31, 2025 and 2024, the assets held in the Trust Account, amounting to $ 306,880,908 and $ 294,617,243 , respectively, were held in mutual funds composed of U.S. treasury securities. Investments in mutual funds are presented on the balance sheets at fair value at the end of each reporting period. The estimated fair values of investments held in the Trust Account are determined using available market information.
Offering Costs
The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consisted principally of professional and registration fees that were related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. The offering costs allocated to the Class A ordinary shares were charged to temporary equity and the offering costs allocated to the Public and Private Placement Warrants were charged to shareholders’ deficit as Public and Private Placement Warrants after management’s evaluation were accounted for under equity treatment.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Convertible Promissory Note – Related Party
The Company accounts for the promissory note (the “Note”) issued on June 16, 2025 to the Sponsor under ASC Topic 470 and is measured at amortized cost. The Note was issued at par and did not include any discount or premium at issuance. Accordingly, the initial carrying value of the Note was equal to the cash proceeds received from the holder, and the Note was recorded at its principal amount on the issuance date. The embedded conversion feature was evaluated under ASC Topic 815 and determined to meet the “own equity” scope exception and therefore bifurcation is not required. No other embedded features require separate recognition. The fair value option under ASC 825 is not permitted.
F- 12
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
The Company accounts for income taxes under ASC 740. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2025 and 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Fair Value Measurements
The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).
Share-Based Compensation
The Company records share-based compensation in accordance with FASB ASC Topic 718, “Compensation-Share Compensation” (“ASC 718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Monte Carlo simulation. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value.
Warrant Instruments
The Company accounts for the Public and Private Placement Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instrument under equity treatment at its assigned value.
F- 13
Class A Shares Subject to Possible Redemption
The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to redemption outside of permanent deficit as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, at December 31, 2025 and 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
At December 31, 2025 and 2024, the Class A ordinary shares subject to redemption reflected in the balance sheets are reconciled in the following table:
Gross proceeds $ 287,500,000
Less:
Proceeds allocated to Public Warrants ( 3,421,250 )
Class A ordinary shares issuance costs ( 19,148,011 )
Plus:
Accretion for Class A ordinary shares to redemption amount 29,686,504
Class A ordinary shares subject to possible redemption, December 31, 2024 294,617,243
Plus:
Accretion for Class A ordinary shares to redemption amount 12,263,665
Class A ordinary shares subject to possible redemption, December 31, 2025 $ 306,880,908
Net Income per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares, and the Company’s income and losses are shared pro rata between the two classes of shares for the year ended December 31, 2025. For the period from March 12, 2024 (inception) through December 31, 2024, the Company had one class of share outstanding – Class B ordinary shares. Net (loss) income per ordinary share is calculated by dividing the net (loss) income by the weighted average shares of ordinary shares outstanding for the respective period.
F- 14
The calculation of diluted net income per ordinary share does not consider the effect of the warrants to purchase an aggregate of 22,712,500 Class A ordinary shares issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following tables present a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary share for each period presented:
For the Year Ended
December 31, 2025 For the Period from
March 12, 2024
(Inception) Through
December 31, 2025
Class A Class B Class A Class B
Basic net income per ordinary share
Numerator:
Allocation of net income, as adjusted $ 4,623,000 $ 1,155,750 $ 3,593,164 $ 1,633,163
Denominator:
Basic weighted average ordinary shares outstanding 28,750,000 7,187,500 14,813,559 6,733,051
Basic net income per ordinary share $ 0.16 $ 0.16 $ 0.24 $ 0.24
For the Year Ended
December 31, 2025 For the Period from
March 12, 2024
(Inception) Through
December 31, 2025
Class A Class B Class A Class B
Diluted net income per ordinary share
Numerator:
Allocation of net income, as adjusted $ 4,623,000 $ 1,115,750 $ 3,518,944 $ 1,707,383
Denominator:
Diluted weighted average ordinary shares outstanding 28,750,000 7,187,500 14,813,559 7,187,500
Diluted net income per ordinary share $ 0.16 $ 0.16 $ 0.24 $ 0.24
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $ 250,000 . Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Recent Accounting Pronouncements
Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, on August 2, 2024 the Company sold 28,750,000 Units, which includes the full exercise by the underwriters of their overallotment option in the amount of 3,750,000 Units, at a purchase price of $ 10.00 per Unit. Each Unit consists of one Class A ordinary share (the “public shares”), and one-half of one redeemable warrant (the “Public Warrants” and, together with the Private Placement Warrants, the “warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment. Each warrant will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation.
F- 15
Warrants
As of December 31, 2025 and 2024, there were 22,712,500 warrants outstanding, including 14,375,000 warrants sold as part of the Units in the Initial Public Offering and 8,337,500 Private Placement Warrants. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment as discussed herein. The warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary shares underlying such unit.
Under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement covering the registration under the Securities Act of the Class A ordinary shares issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the Company’s initial Business Combination and to maintain a current prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable.
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $ 18.00
The Company may redeem the outstanding warrants:
● in whole and not in part;
● at a price of $ 0.01 per warrant;
● upon a minimum of 30 days’ prior written notice of redemption (the “ 30 -day redemption period”); and
● if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $ 18.00 per share for any 20 trading days within a 30 -trading day period commencing at least 150 days after completion of the initial Business Combination and ending on the third trading day prior to the date on which the Company sends to the notice of redemption to the warrant holders.
Additionally, if the number of outstanding Class A ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a subdivision of ordinary shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the quotient of (x) the price per class A ordinary share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class A ordinary shares as reported during the ten ( 10 ) trading day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.
F- 16
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Original Sponsor and Cantor Fitzgerald & Co., the representative of the underwriters, purchased an aggregate of 8,337,500 Private Placement Warrants, each exercisable to purchase one Class A ordinary share at $ 11.50 per share, at a price of $ 1.00 per warrant, or $ 8,337,500 in the aggregate. Of those 8,337,500 Private Placement Warrants, the Original Sponsor purchased 5,043,750 Private Placement Warrants and Cantor Fitzgerald & Co. purchased 3,293,750 Private Placement Warrants. Certain institutional investors who are not affiliated with any member of management (the “non-managing sponsor investors”), the Original Sponsor or any other investor in the Original Sponsor provided approximately 50.1 % of the capital utilized by the Original Sponsor to purchase the Private Placement Warrants and, as a result, indirectly hold approximately 50.1 % of such warrants. Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment.
The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Original Sponsor, Cantor Fitzgerald & Co. or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (ii) will be entitled to registration rights and (iii) with respect to Private Placement Warrants held by Cantor Fitzgerald & Co. and/or its designees, will not be exercisable more than five years from the date of the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule 5110(g)(8).
On May 23, 2025, the Original Sponsor, the Sponsor and the Company (only for the purposes of facilitating the purchase and share transfer) entered into the Securities Purchase Agreement, pursuant to which the Original Sponsor agreed to sell, and the Sponsor agreed to purchase, 7,187,500 Class B ordinary shares, par value $ 0.0001 per share, and 5,043,750 Private Placement Warrants of the Company owned by the Original Sponsor for an aggregate purchase price of $ 6,467,500 . The transactions contemplated by the Securities Purchase Agreement were consummated on May 27, 2025. At the Closing, the Original Sponsor delivered to the Sponsor an assignment of the Transferred Sponsor SPAC Securities against payment of the Closing Cash Purchase Price. Also on May 27, 2025, the Sponsor entered into an agreement to purchase 3,293,750 additional Private Placement Warrants of the Company from Cantor Fitzgerald & Co. for an aggregate purchase price of $ 10 , which was consummated on May 27, 2025, upon which Cantor Fitzgerald & Co. delivered to the Sponsor an assignment of the Cantor Warrants.
The Original Sponsor, officers and directors have entered into the Letter Agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100 % of the public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination.
Pursuant to the Securities Purchase Agreement, on May 27, 2025, the Company entered into an Assignment and Assumption Agreement with the Sponsor, the Original Sponsor and the Company’s directors and executive officers, pursuant to which the Original Sponsor assigned to the Sponsor, and the Sponsor assumed, all of Original Sponsor’s rights, title and interests under the Letter Agreement, and the Sponsor agreed to be bound by all terms, conditions, and covenants and be entitled to all the terms and provisions therein. The Company also entered into an Assignment and Assumption Agreement with the Sponsor and the Original Sponsor, pursuant to which the Original Sponsor assigned to the Sponsor, and the Sponsor assumed, all of Original Sponsor’s rights, title and interests under the Registration Rights Agreement, dated as of July 31, 2024, by and among the Company, Original Sponsor and Cantor Fitzgerald & Co., pursuant to which the Sponsor agreed to be bound by all terms, conditions, and covenants and be entitled to all the terms and provisions therein.
F- 17
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On March 15, 2024, the Original Sponsor made a capital contribution of $ 25,000 , or approximately $ 0.004 per share, to cover certain of the Company’s expenses, for which the Company issued 7,187,500 founders shares to the Original Sponsor. As the underwriters’ over-allotment was exercised in full as part of the Initial Public Offering, none of the founder shares are subject to forfeiture.
The Company’s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof until the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial shareholders with respect to any founder shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price of the Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for share subdivisions, share capitalizations, share consolidations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the Lock-up.
On May 23, 2025, the Original Sponsor, the Sponsor and the Company (only for the purposes of facilitating the purchase and share transfer) entered into the Securities Purchase Agreement, pursuant to which the Original Sponsor agreed to sell, and the Sponsor agreed to purchase, 7,187,500 Class B ordinary shares, par value $ 0.0001 per share, and 5,043,750 Private Placement Warrants of the Company owned by the Original Sponsor for an aggregate purchase price of $ 6,467,500 . The transactions contemplated by the Securities Purchase Agreement were consummated on May 27, 2025. At the Closing, the Original Sponsor delivered to the Sponsor an assignment of the Transferred Sponsor SPAC Securities against payment of the Closing Cash Purchase Price.
Convertible Promissory Note — Related Party
The Original Sponsor had agreed to loan the Company an aggregate of up to $ 300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan was non-interest bearing, unsecured and due on demand. As of the Initial Public Offering, the loan was repaid and was no longer available to be drawn upon.
On June 16, 2025, the Company issued a promissory note (the “Note”) to the Sponsor, pursuant to which the Company can borrow up to an aggregate principal amount of $ 2,500,000 from the Sponsor. The Note bears no interest and is payable in full upon the consummation of the Company’s initial business combination (the “Maturity Date”). A failure to pay the principal on the Maturity Date shall be deemed an event of default, in which case the Note may be accelerated. Upon consummation of a Business Combination, Sponsor shall have the option, but not the obligation, to convert up to $ 1,500,000 of the outstanding unpaid principal balance under this Note, into Private Placement Warrants at the purchase price of $ 1.00 per Private Placement Warrant, each such Private Placement Warrant exercisable to purchase one Class A ordinary share of the Company at $ 11.50 per share, subject to adjustment. If the Company does not consummate an initial business combination, the Note will be repaid solely to the extent the Company has funds available outside its trust account established in connection with the Company’s initial public offering. On June 18, 2025, September 19, 2025 and December 22, 2025, the Company borrowed $ 500,000 , $ 1,500,000 and $ 500,000 , respectively, under the Note. The proceeds of the Note will be used to provide the Company with general working capital. As of December 31, 2025 and 2024, there were $ 2,500,000 and $ 0 , respectively, outstanding under the Note.
The Company accounts for the Note in accordance with ASC 470. The Company evaluated the embedded features of the Note and determined that the embedded derivative does not require bifurcation under applicable accounting guidance.
The Note was issued in a related-party transaction with the Sponsor that was not conducted at arm’s length and is therefore measured at amortized cost. The Note was issued at par and did not include a discount or premium at issuance. Accordingly, the initial carrying value of the Note was equal to the cash proceeds received from the holder, and the Note was recorded at its principal amount on the issuance date.
F- 18
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $ 1,500,000 of such Working Capital Loans, which would include any potential borrowings under the Note, may be convertible into private placement warrants of the post Business Combination entity at a price of $ 1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants.
Advance from Related Party
The Original Sponsor has advanced the Company $ 280,545 to be used for expenses related to the Initial Public Offering. Subsequently, the Original Sponsor advanced an additional $ 98,212 and $ 76,338 to the Company as of December 31, 2024 and during the year ended December 31, 2025, respectively. On April 4, 2025 and May 23, 2025, the Company repaid the Original Sponsor $ 378,757 and $ 51,898 , respectively, of these outstanding advances.
As of December 31, 2025 and 2024, the Company had no advances from related party, respectively.
Related Party Contribution
During the year ended December 31, 2025, the Company recorded $ 24,440 as an advance from a related party for the payment of certain operating expenses on behalf of the Company. The advance was made by the Company’s Original Sponsor. Subsequent to the payment of these expenses, the Original Sponsor indicated that it does not intend to seek reimbursement from the Company.
Accordingly, the Company determined that the amount represents a capital contribution from the Original Sponsor rather than a payable. As a result, the Company reclassified the $ 24,440 from advance from related party to additional paid-in capital in the accompanying financial statements.
Due from Related Party
As of December 31, 2025, the Company recorded a balance of $ 527 due from related party. The balance arose from an overpayment made in connection with amounts due under a promissory note with the Original Sponsor.
Non-Employee Director Compensation
On June 26, 2025, the Company adopted a Non-Employee Director Compensation Plan to attract and retain highly qualified individuals to serve as non-employee directors. Effective October 1, 2025, the Company began making cash payments to its non-employee directors for Board service, with payments made in arrears to cover services provided since June 2025. For the year ended December 31, 2025 and 2024, the Company recognized $ 1,617,000 and $ 0 , respectively, in director compensation expense within its statements of operations. The related accrued compensation, included in accrued expenses on the balance sheets, was $ 891,500 and $ 0 as of December 31, 2025 and 2024, respectively.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the founder shares, Private Placement Warrants and the Class A ordinary shares underlying such Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans have registration rights to require the Company to register a sale of any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
F- 19
Equity PIPE Subscription Agreement
Contemporaneously with the execution of the Business Combination Agreement, on July 7, 2025, certain investors (the “Equity PIPE Investors”) entered into subscription agreements (collectively, the “Equity PIPE Subscription Agreements”) with ReserveOne, Pubco, and solely with respect to Section 8(u) thereof, the Company, pursuant to which the Equity PIPE Investors agreed to purchase up to an aggregate of $ 500,000,000 of (a) either (i) ReserveOne Common Shares or (ii) in the event the issuance of ReserveOne Common Shares would, in the opinion of the Company, ReserveOne or Pubco on the advice of any of their respective legal counsel, adversely affect the treatment of the Transactions under Section 351 of the Internal Revenue Code of 1986 (the “Code”), shares Pubco Class A common stock (the “Equity PIPE Shares”) and (b) either (i) ReserveOne Warrants or (ii) in the event the issuance of ReserveOne Warrants would, in the opinion of the Company, ReserveOne or Pubco and on the advice of their respective legal counsel, adversely affect the treatment of the Transactions under Section 351 of the Internal Revenue Code of 1986, Pubco Warrants (“PIPE Warrants” and, together with the Equity PIPE Shares, the “Equity PIPE Securities”) at an aggregate purchase price of $ 10.00 , which $ 10.00 will entitle Equity PIPE Investors to one Equity PIPE Share and one PIPE Warrant, in a private placement (the “Equity PIPE”). The PIPE Warrants (and the shares underlying the PIPE Warrants, the “Warrant Shares”) will be issued pursuant to a Warrant Agreement by and among ReserveOne, Pubco and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”). The Equity PIPE Investors are permitted, under the Equity PIPE Subscription Agreements, to satisfy their commitments thereunder if they hold Company Class A ordinary shares that qualify as Non-Redeemed Shares (as defined in the PIPE Subscription Agreement), subject to certain conditions and restrictions set forth in the Equity PIPE Subscription Agreements. The purchase price for the Equity PIPE Securities may be paid in either cash or Bitcoin, at the sole election of each of the Equity PIPE Investors.
The closing of the Equity PIPE is contingent upon the satisfaction of all closing conditions to consummate the Transactions and the Equity PIPE Investors’ consent to any amendments, modifications or waivers to the terms of the Business Combination Agreement that would reasonably be expected to materially and adversely affect the economic benefits of the Equity PIPE Investors, among other customary closing conditions.
Pursuant to the Equity PIPE Subscription Agreements, the Company and Pubco have agreed to use commercially reasonable efforts to cause the Equity PIPE Securities and Warrant Shares to be registered on the Registration Statement. To the extent that any Equity PIPE Securities and Warrant Shares are unable to be included on the Registration Statement, Pubco has agreed to register and maintain the registration of the Equity PIPE Securities and Warrant Shares by filing a resale registration statement with the SEC within 30 calendar days after the Closing (at Pubco’s sole cost and expense), to register the resale of the Equity PIPE Securities and Warrant Shares. Pubco has agreed to use its commercially reasonable efforts to have such resale registration statement declared effective as soon as practicable after the filing thereof, but no later than 60 calendar days after the Closing, which may be extended an additional 30 calendar days depending on whether the SEC issues comments on the resale registration statement.
Each Equity PIPE Subscription Agreement will terminate and be void and of no further force and effect, subject to certain exceptions, upon the earliest to occur of (i) such date and time as the Business Combination Agreement is terminated in accordance with its terms; (ii) the mutual written agreement of the respective parties to terminate such agreement; or (iii) July 7, 2026.
Convertible Note Subscription Agreement
Contemporaneously with the execution of the Business Combination Agreement, on July 7, 2025, certain investors entered into subscription agreements (the “Convertible Notes Subscription Agreements” and such investors, the “Convertible Notes Investors”) with Pubco, and, solely with respect to Section 9(t) thereof, the Company, pursuant to which the Convertible Notes Investors have agreed to purchase up to $ 250,000,000 in aggregate principal amount of Pubco’s 1.00 % Convertible Senior Notes (the “Initial Convertible Notes” and such subscriptions, including the purchase of any Option Convertible Notes (as defined below), the “Convertible Notes PIPE,” and together with the Equity PIPE, the “PIPE Investments”), upon the terms and subject to the conditions set forth therein. In addition, for a period of 30 days following the execution of the Convertible Notes Subscription Agreements, Pubco has granted the Convertible Notes Investors an option to purchase additional convertible notes in an aggregate principal amount of up to $ 50 million, on a pro rata basis based on such Convertible Notes Investor’s subscription for Initial Convertible Notes (the “Option Convertible Notes” and, together with the Initial Convertible Notes, the “Convertible Notes”).
The net proceeds of the Convertible Notes PIPE will be converted into Bitcoin.
The closing of the Convertible Notes PIPE is contingent upon the satisfaction of all closing conditions to consummate the Transactions and the Convertible Notes Investors’ consent to any amendments, modifications or waivers to the terms of the Business Combination Agreement that are material and adverse economically to the Convertible Notes Investors, among other customary closing conditions.
Pursuant to the Convertible Notes Subscription Agreements, Pubco has agreed to register and maintain the registration of the Pubco Class A Common Shares issuable upon conversion of the Convertible Notes by filing a resale registration statement with the SEC within 30 calendar days after the Closing (at Pubco’s sole cost and expense), to register the resale of the Pubco Class A Common Shares. Pubco has agreed to use its commercially reasonable efforts to have such resale registration statement declared effective as soon as practicable after the filing thereof, but no later than 60 calendar days after the Closing, which may be extended an additional 30 calendar days depending on whether the SEC issues comments on the resale registration statement.
F- 20
Amended and Restated Registration Rights Agreement
Concurrently with the consummation of the transactions contemplated by the Business Combination Agreement, the Company, Pubco, the Sponsor, the Sponsor Parent and the MI7 Holder will enter into a registration rights agreement that will amend and restate the current registration rights agreement entered into at the time of the Company’s initial public offering between the Company and the Original Sponsor (the “Amended and Restated Registration Rights Agreement”), pursuant to which Pubco will (i) assume the registration obligations of the Company under such registration rights agreement and (ii) provide registration rights with respect to the resale of the Registrable Securities (as defined the Amended and Restated Registration Rights Agreement) held by the Sponsor, the Sponsor Parent and the MI7 Holder.
Underwriters’ Agreement
The underwriters had a 45 -day option from the date of the Initial Public Offering to purchase up to an additional 3,750,000 units to cover over-allotments, if any. On August 1, 2024, the underwriters elected to fully exercise the over-allotment option to purchase the additional 3,750,000 Units at a price of $ 10.00 per Unit.
The underwriters were entitled to a cash underwriting discount of $ 5,000,000 ( 2.0 % of the gross proceeds of the Units offered in the Initial Public Offering, excluding any proceeds from Units sold pursuant to the underwriters’ over-allotment option), which was paid upon the closing of the Initial Public Offering. Additionally, the underwriters are entitled to a deferred underwriting discount of 4.40 % of the gross proceeds of the Initial Public Offering held in the Trust Account other than those sold pursuant to the underwriters’ over-allotment option and 6.40 % of the gross proceeds sold pursuant to the underwriters’ over-allotment option, or $ 13,400,000 in the aggregate, payable upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement.
Risks and Uncertainties
The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine, Israel-Hamas and U.S.-Israel-Iran conflicts, as well as the changes in the economic and strategic policies of the United States. Although the length and impact of these circumstances are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, import costs, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any new sanctions or economic policies could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from these circumstances and subsequent sanctions or other actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
Business Combination Agreement
On July 7, 2025, the Company, ReserveOne, Pubco, the Merger Subs, entered into the Business Combination Agreement.
As a result of the transactions contemplated by the Business Combination Agreement, the Company will be de-registered in the Cayman Islands and register by way of continuation to the State of Delaware and domesticate as a Delaware corporation.
Following the Domestication, SPAC Merger Sub will merge with and into the Company , with the Company continuing as the surviving entity, and as a result of which the Company will be a wholly-owned subsidiary of Pubco. Promptly following the SPAC Merger, Company Merger Sub will merge with and into ReserveOne, with ReserveOne continuing as the surviving company, and as a result of which ReserveOne will be a wholly-owned subsidiary of Pubco.
As a result of the Mergers, Pubco will become a publicly traded company, all upon the terms and subject to the conditions set forth in the Business Combination Agreement and in accordance with applicable laws.
The shares of Pubco Class A common stock, par value $ 0.0001 per share, will be listed for trading and will be freely transferable, subject to the transfer restrictions set forth in the Sponsor Support Agreement and the Lock-Up Agreement and any restrictions pursuant to applicable laws. The shares of Pubco Class B common stock, par value $ 0.0001 per share, will not be listed or freely transferable.
The Closing is expected to occur in the second quarter of 2026, subject to the satisfaction of certain customary closing conditions.
On July 16, 2025, the Company and the Sponsor entered into the Note Amendment, solely to correct a scrivener’s error regarding the Sponsor’s option to convert up to $ 1,500,000 of the outstanding unpaid principal balance under the Note into Private Placement Warrants at a purchase price of $ 1.50 per Private Placement Warrant. Pursuant to the Note Amendment, the purchase price per Private Placement Warrant was corrected to reflect a purchase price of $ 1.00 per Private Placement Warrant upon conversion under the Note. All other terms of the Note remain unchanged.
F- 21
NOTE 7. SHAREHOLDERS’ DEFICIT
Preferred Shares — The Company is authorized to issue a total of 1,000,000 preferred shares at par value of $ 0.0001 each. At December 31, 2025 and 2024, there were no preferred shares issued or outstanding.
Class A Ordinary Shares — The Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $ 0.0001 each. At December 31, 2025 and 2024, there were no Class A ordinary shares issued or outstanding, excluding 28,750,000 Class A ordinary shares subject to possible redemption.
Class B Ordinary Shares — The Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $ 0.0001 each. As of December 31, 2025 and 2024, there were 7,187,500 Class B ordinary shares issued and outstanding. The founder shares included an aggregate of up to 937,500 shares subject to forfeiture if the over-allotment option was not exercised by the underwriters in full. On August 1, 2024, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 937,500 founder shares were no longer subject to forfeiture.
The founder shares will automatically convert into Class A ordinary shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, share consolidations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, 20 % of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of the Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one-for-one basis.
Notwithstanding the foregoing, pursuant to the terms of the Business Combination Agreement, upon the consummation of the proposed Business Combination, the founder shares will convert, on a one-for-one basis, into one share of Class A-2 common stock of ReserveOne, par value $ 0.0001 per share (the “ ReserveOne Class A-2 Common Shares ”) and then each issued and outstanding ReserveOne Class A-2 Common Share will be automatically canceled and extinguished and converted into and thereafter represent the right to receive one share of Pubco Class B common stock, par value $ 0.0001 per share (the “ Pubco Class B Common Shares ”), following which, all Company Class A-2 Common Shares will cease to be outstanding and will automatically be canceled and will cease to exist. Following the consummation of the transactions contemplated by the Business Combination Agreement, each Pubco Class B Common Share will be entitled to ten votes per share on each matter submitted for a vote of Pubco’s shareholders. In addition, upon consummation of the proposed Business Combination and in lieu of the anti-dilution provisions described in the prior paragraph, the Sponsor will receive an additional 5.5 million Pubco Class B Common Shares, of which 5 million shares are subject to forfeiture pursuant to the terms of the Business Combination Agreement.
Holders of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders.
NOTE 8. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability.
F- 22
The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. There were no transfers between levels of fair value hierarchy during the periods ended December 31, 2025 and 2024.
December 31, 2025
Quoted
Prices in Significant
Other Significant
Other
Active
Markets Observable
Inputs Unobservable
Inputs
Description (Level 1) (Level 2) (Level 3)
Assets:
Investments held in Trust Account – mutual funds $ 306,880,908 $ — $ —
December 31, 2024
Quoted
Prices in Significant
Other Significant
Other
Active
Markets Observable
Inputs Unobservable
Inputs
Description (Level 1) (Level 2) (Level 3)
Assets:
Investments held in Trust Account – mutual funds $ 294,617,243 $ — $ —
The following table presents information about the Company’s assets that are measured at fair value on August 2, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Level August 2,
2024
Equity:
Fair value of Public Warrants for Class A ordinary shares subject to redemption allocation 3 $ 3,421,250
The fair value of Public Warrants was determined using a binomial-lattice model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants:
August 2,
2024
Underlying stock price $ 9.92
Exercise price 11.50
Term (years) 4.70
Risk-free rate 3.61 %
Volatility 1.0 %
Probability of completion a Business Combination 60.0 %
NOTE 9. SEGMENT INFORMATION
ASC Topic 280, ”Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s Chief Operating Decision Maker (“CODM”), or group, in deciding how to allocate resources and assess performance.
The Company’s CODM has been identified as the Chief Executive Officer , who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reporting segment.
F- 23
The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net income or loss. The measure of segment assets is reported on the balance sheets as total assets
When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:
For the Year Ended
December 31,
2025 For the
Period from
March 12,
2024 (Inception) Through
December 31,
2024
General and operating costs $ 6,484,916 $ 453,416
Interest earned on investments held in Trust Account $ 12,263,666 $ 5,679,743
December 31,
2025 December 31,
2024
Cash $ 1,175,051 $ 821,188
Investments held in Trust Account $ 306,880,908 $ 294,617,243
The CODM reviews interest earned on investments held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the statements of operations, are the significant segment expenses provided to the CODM on a regular basis. All other segment items included in net income or loss are reported on the statements of operations and described within their respective disclosures.
The accounting policies used to measure the profit and loss of the segment are the same as those described in the summary of significant accounting policies.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than the matter described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
On February 18, 2026, the Company issued a promissory note (the “Second Sponsor Note”) to the Sponsor, pursuant to which the Company can borrow up to an aggregate principal amount of $ 2,000,000 from the Sponsor. On February 18, 2026, the Company borrowed $ 600,000 on the Second Sponsor Note. The proceeds of the Sponsor Note will be used for general working capital purposes. The Second Sponsor Note bears no interest and is payable in full upon the consummation of our initial business combination.
F- 24
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.